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Neuropathologic Role of Inositol (1,4,5)-Trisphosphate Receptor Proteolysis
Abstract
Ischemic brain injury represents a major cause of death and disability. Developing targeted therapies for
neuroprotection requires increased understanding of the molecular mechanisms of neuronal injury
following ischemia. Both disruption of Ca2+ homeostasis and pathological activation of proteases are
believed to play causal roles in delayed neuronal death after ischemia-reperfusion. Presented here are
data supporting a novel role for proteolysis of an intracellular Ca2+ release channel, inositol
1,4,5-trisphosphate receptor (InsP3R), in ischemic brain injury. We identified a unique calpain cleavage site
in the type 1 InsP3R (InsP3R1) and utilized a recombinant truncated form of the channel (capn-InsP3R1)
to investigate the functional consequences of InsP3R1 proteolysis. Using a combination of single-channel
electrophysiology and single-cell Ca2+ imaging, we determined that capn-InsP3R1 has InsP3-independent
gating and constitutive channel activity. This constitutive channel activity decreased Ca2+ content of
intracellular stores in Neuro-2A cells by increasing endoplasmic reticulum (ER) Ca2+ leak. Additionally,
capn-InsP3R1 compromised ER Ca2+ buffering capacity in primary cortical cultures, leading to decreased
neuronal viability and enhanced sensitivity to excitotoxic injury. Using stereotaxic intracerebral injection of
viral vectors, we transduced neurons in vivo with capn-InsP3R1 and observed spontaneous degeneration
of subpopulations of neurons in the hippocampus. Together, these results reveal a previously unknown
role of calpain-cleaved InsP3R1 in disruption of intracellular Ca2+ homeostasis and neuronal death.
Importantly, we also provide evidence of calpain-mediated proteolysis of InsP3R1 in neurons in the
cerebellum after ischemic brain injury. The findings presented here provide the first functional studies of
calpain-cleaved InsP3R1, and advance our understanding of the pathological role of the cleaved channel
in neurodegeneration. Inhibiting Ca2+ release through calpain-cleaved InsP3R1 may emerge as a novel
therapeutic strategy for intervention in ischemic brain injury and other neurodegenerative diseases
associated with disruption of Ca2+ homeostasis.
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ABSTRACT
NEUROPATHOLOGIC ROLE OF INOSITOL (1,4,5)-TRISPHOSPHATE
RECEPTOR PROTEOLYSIS

Catherine M. Kopil
Robert W. Neumar

Ischemic brain injury represents a major cause of death and disability. Developing
targeted therapies for neuroprotection requires increased understanding of the molecular
mechanisms of neuronal injury following ischemia. Both disruption of Ca2+ homeostasis
and pathological activation of proteases are believed to play causal roles in delayed
neuronal death after ischemia-reperfusion. Presented here are data supporting a novel
role for proteolysis of an intracellular Ca2+ release channel, inositol 1,4,5-trisphosphate
receptor (InsP3R), in ischemic brain injury. We identified a unique calpain cleavage site
in the type 1 InsP3R (InsP3R1) and utilized a recombinant truncated form of the channel
(capn-InsP3R1) to investigate the functional consequences of InsP3R1 proteolysis. Using
a combination of single-channel electrophysiology and single-cell Ca2+ imaging, we
determined that capn-InsP3R1 has InsP3-independent gating and constitutive channel
activity. This constitutive channel activity decreased Ca2+ content of intracellular stores
in Neuro-2A cells by increasing endoplasmic reticulum (ER) Ca2+ leak. Additionally,
capn-InsP3R1 compromised ER Ca2+ buffering capacity in primary cortical cultures,
v

leading to decreased neuronal viability and enhanced sensitivity to excitotoxic injury.
Using stereotaxic intracerebral injection of viral vectors, we transduced neurons in vivo
with capn-InsP3R1 and observed spontaneous degeneration of subpopulations of neurons
in the hippocampus. Together, these results reveal a previously unknown role of calpaincleaved InsP3R1 in disruption of intracellular Ca2+ homeostasis and neuronal death.
Importantly, we also provide evidence of calpain-mediated proteolysis of InsP3R1 in
neurons in the cerebellum after ischemic brain injury. The findings presented here
provide the first functional studies of calpain-cleaved InsP3R1, and advance our
understanding of the pathological role of the cleaved channel in neurodegeneration.
Inhibiting Ca2+ release through calpain-cleaved InsP3R1 may emerge as a novel
therapeutic strategy for intervention in ischemic brain injury and other neurodegenerative
diseases associated with disruption of Ca2+ homeostasis.
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INTRODUCTION

The long-term goal of this project is to understand the mechanisms of neuronal
Ca2+ dysregulation that contribute to delayed neuronal death after ischemic brain injury.
Ca2+ homeostasis in post-ischemic neurons is potentially disrupted by proteolytic
modification of Ca2+ regulatory proteins. This dissertation focuses on calpain-mediated
cleavage of the endoplasmic reticulum (ER) Ca2+ release channel inositol (1,4,5)trisphosphate receptor (InsP3R). Previously published studies and data presented in this
dissertation suggest that type 1 InsP3R (InsP3R1) is a target for proteolysis following
ischemia, and that the cleaved channel has dysregulated gating and leaks Ca2+ from ER
stores. Based on these findings, we hypothesize that calpain proteolysis of InsP3R1 plays
a causal role in Ca2+ dysregulation and neuronal death following ischemic brain injury.
The results presented in this thesis provide fundamental understanding of the mechanisms
by which calpain proteolysis of InsP3R1 could cause neurodegeneration through
pathological disruption of intracellular Ca2+ homeostasis.

Ischemic Brain Injury
Each year, more than 300,000 people in the United States suffer global brain
ischemia due to cardiac arrest (Lloyd-Jones et al., 2010), often resulting in death or
severe, long-term disability (CDC, 2001). Despite extensive clinical and basic science
research in ischemic brain injury, the prognosis for patients remains poor. Treatment for
1

cardiac arrest targets early reperfusion and restoration of blood flow, as the severity of
neurological injury depends on the duration of ischemia. Periods of ischemia that are
sufficient to trigger depolarization of neuronal plasma membranes are widely known to
activate molecular injury mechanisms leading to neuronal death (Kristian and Siesjo,
1998; Neumar, 2000; Szydlowska and Tymianski, 2010). In global brain ischemia, as
occurs with cardiac arrest, ischemia-induced membrane depolarization occurs within 1 or
2 min of cessation of blood flow (Nakashima et al., 1995). Resuscitation and survival
after prolonged cardiac arrest is uncommon.

Thus, nearly all patients who are

successfully resuscitated experience brief to intermediate durations of ischemic
depolarization (5 to 30 min) followed by reperfusion (Neumar, 2000). Reperfusion after
these durations of global ischemia typically results in initial restoration of adenosine
trisphosphate (ATP) synthesis (Sims, 1992) and neuronal membrane repolarization
(Silver and Erecinska, 1992). Despite this apparent return of physiological function
however, subpopulations of neurons eventually undergo delayed cell death following
ischemia-reperfusion.
Interestingly,

transient

global

brain

ischemia

results

in

selective

neurodegeneration. Vulnerable neuron populations include CA1 pyramidal neurons in
hippocampus, Purkinje cells in cerebellum, small and medium spiny neurons in the
dorsolateral striatum, and neurons in layers 3 and 5 of cortex (Pulsinelli et al., 1982;
Smith et al., 1984; Pulsinelli, 1985; Katz et al., 1995; Yamashima et al., 2003; Hara et al.,
2007). Cells outside of these selectively vulnerable areas are usually unaffected by brief
durations of ischemia experienced by most cardiac arrest survivors.

Within the

vulnerable brain regions, neuronal death is delayed hours to days after the initial ischemic
2

event (Kirino, 1982; Pulsinelli et al., 1982; Kirino et al., 1984; Smith et al., 1984;
Yamashima et al., 2003). Therefore, there is a potentially wide therapeutic window for
neuroprotective interventions following cardiac arrest and ischemic brain injury.
Identifying the molecular events that cause delayed post-ischemic neuronal death
is essential to developing innovative, targeted therapies. However, nearly 3 decades after
delayed neuronal death was first documented, the precise mechanisms responsible are not
yet fully understood. Impaired Ca2+ homeostasis, pathological protease activation,
mitochondrial dysfunction, activation of the unfolded protein response, altered gene
expression, and inflammation have all been identified as molecular mechanisms of postischemic neuronal injury (Kristian and Siesjo, 1998; Fiskum et al., 1999; Neumar, 2000;
Paschen and Mengesdorf, 2005; Zipp and Aktas, 2006; Bevers and Neumar, 2008;
Szydlowska and Tymianski, 2010). Cross-talk between these pathways has been well
established, and may play a critical role in the ultimate execution of cell death following
ischemia-reperfusion.

Particularly relevant to this dissertation, protease-mediated

cleavage of Ca2+ regulatory proteins has emerged as a novel mechanism that links
pathological activation of proteases to irreversible disruption of neuronal Ca2+
homeostasis (Bevers and Neumar, 2008). Proteolytically modified Ca2+ channels that
become dysregulated following cleavage could represent novel therapeutic targets for
reducing neuronal pathology and degeneration after ischemic brain injury.
Disruption of Neuronal Ca2+ Homeostasis during Ischemia and Reperfusion
Calcium is a universal intracellular messenger, essential to proper neuronal
function and survival. A diverse array of ion channels, buffers, pumps and exchangers
3

work in concert to allow for dynamic and tight regulation of neuronal Ca2+ signaling
(Berridge et al., 2000; Berridge et al., 2003).

Disruption of these molecular Ca2+-

homeostatic mechanisms can serve as a trigger for cell death (Berridge et al., 2000;
Berridge et al., 2003; Orrenius et al., 2003; Mattson, 2007; Zhivotovsky and Orrenius,
2011). Brain ischemia and reperfusion dramatically disrupts neuronal Ca2+ homeostasis,
and there is compelling evidence for a causal role of Ca2+ overload in post-ischemic
neuronal death.
Ischemic Depolarization
Brain ischemia initiates a number of cellular events that dramatically increase
cytoplasmic free Ca2+ concentration ([Ca2+]i) in neurons. Loss of blood flow to the brain
results in oxygen and glucose deprivation, which depletes neuronal energy stores
(Dirnagl et al., 1999). Without ATP, neurons are unable to maintain the electrochemical
gradients across their plasma membrane. This ischemic depolarization activates voltagegated Ca2+ channels, leading to Ca2+ influx from the extracellular space. Depolarization
and elevated presynaptic [Ca2+]i stimulate release of neurotransmitters, including the
excitatory amino acid glutamate. Glutamate, in turn, acts to further increase [Ca2+]i
through activation of its postsynaptic ionotropic and metabotropic receptors (Michaelis,
1998). Glutamate binding to N-methyl-D-aspartate (NMDA) receptors enhances neuronal
Ca2+ influx, where as binding to G-protein coupled receptors releases Ca2+ from
intracellular stores via InsP3 signaling. In addition to ATP depletion and membrane
depolarization, changes in cellular pH and production of reactive oxygen species (ROS)
associated with ischemia increase [Ca2+]i through activation of Ca2+-permeable transient
4

receptor potential channels (Aarts et al., 2003) and acid-sensing ion channels (Allen and
Attwell, 2002; Xiong et al., 2004).
Ischemia also impairs normal cellular mechanisms for removing Ca2+ from the
cytoplasm. Sustained depolarization and loss of the Na+ gradient changes the direction of
the Na+/Ca2+ exchanger (NCX), transporting Na+ out of the cell and Ca2+ into the cell
(Jeffs et al., 2007). Additionally, depleted energy stores during ischemia prevent energydependent Ca2+ pumps, located on intracellular stores and the plasma membrane, from
removing Ca2+ from the cytoplasm. In global ischemia, these aberrant Ca2+ signaling
events and the resulting elevation in [Ca2+]i can occur to varying degrees in all neurons
throughout the brain.
Changes in [Ca2+]i with Ischemia-Reperfusion
In selectively vulnerable neurons, ischemia-induced disruption of neuronal Ca2+
homeostasis generates a 100- to 1,000-fold transient increase in [Ca2+]i. Intracellular
microelectrode measurements from CA1 hippocampal neurons in vivo have demonstrated
an increase in [Ca2+]i from a baseline of 60-90 nM to a peak of 20-200 µM with 8 min of
low-flow ischemia (Silver and Erecinska, 1990; Erecinska and Silver, 1992; Silver and
Erecinska, 1992). Interestingly, measurements from CA3 hippocampal neurons in the
same animals revealed changes in [Ca2+]i that were much smaller (mean peak ~3 µM)
than those observed in CA1 neurons (Erecinska and Silver, 1992; Silver and Erecinska,
1992). Increases in neuronal [Ca2+]i during ischemia correspond to a modest, but
significant decrease in extracellular [Ca2+] ([Ca2+]e), suggesting that Ca2+ influx from the
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extracellular space is primarily responsible for the initial rise in [Ca2+]i (Nicholson et al.,
1977; Hansen, 1985; Silver and Erecinska, 1992).
With restoration of blood flow, energy stores are replenished (Sims, 1992) and
neurons are able to repolarize (Silver and Erecinska, 1992). As a result, physiological
Ca2+ homeostasis is restored in neurons. Specifically, [Ca2+]i returns to pre-ischemic
levels within 20 min and [Ca2+]e reaches baseline levels with longer periods of
reperfusion (Silver and Erecinska, 1990, 1992).

The repolarization of neuronal

membranes and reinstatement of normal [Ca2+]i following reperfusion proves that
vulnerable neurons are not dead immediately following ischemic brain injury. This
highlights the truly delayed nature of post-ischemic neurodegeneration, and suggests that
secondary damage is responsible for neuronal death.
A secondary rise in [Ca2+]i occurs selectively in neurons that undergo delayed cell
death after ischemia. Microelectrode measurements from CA1 hippocampal neurons
indicate that a second rise in [Ca2+]i begins as early as 2 h following ischemia-reperfusion
(Silver and Erecinska, 1992).

More crude measurements of total tissue [Ca2+] or

ultrastructural localization of neuronal Ca2+ deposits reveal significant accumulation of
Ca2+ hours to days after ischemia, depending on the injury severity and animal model
(Simon et al., 1984; Deshpande et al., 1987; Kumar et al., 1987; Martins et al., 1988).
These secondary rises in [Ca2+]i are specific to selectively vulnerable neurons and do not
occur in CA3 pyramidal cells or other neuronal populations that exhibit limited signs of
injury following ischemia (Martins et al., 1988; Silver and Erecinska, 1992).
Importantly, the secondary rise in [Ca2+]i and intracellular accumulation of Ca2+
following

ischemia-reperfusion

consistently
6

precede

histological

evidence

of

neurodegeneration. This suggests that delayed, secondary elevation of [Ca2+]i may signal
or initiate neuronal cell death. In contrast to the initial, reversible increase in [Ca2+]i
following ischemia, which is predominately related to Ca2+ influx from the extracellular
space, the source of the secondary increase in neuronal [Ca2+]i is unknown.
How might delayed, secondary rises in [Ca2+]i lead to execution of neuronal
death? Sustained elevations in [Ca2+]i could exert adverse effects by acting directly or
indirectly on numerous cell death pathways. For example, Ca2+ could trigger delayed
post-ischemic neurodegeneration through oxidative stress and mitochondrial dysfunction,
or by pathological activation of phosopholipases, endonucleases, and proteases (Kristian
and Siesjo, 1998; Neumar, 2000; Szydlowska and Tymianski, 2010). Ca2+-dependent
activation of cytoplasmic calpain proteases in particular provides a potentially important
feed-forward mechanism for executing cell death. Calpains have been shown to cleave a
number of Ca2+ regulatory proteins following ischemia, leading to altered substrate
function (Bevers and Neumar, 2008; Vosler et al., 2008). Dysfunction of Ca2+ regulatory
proteins mediated by calpain proteolysis likely contributes to the delayed, secondary rise
in [Ca2+]i, and could lead to further activation of calpains and eventual necrotic cell death.
Alterations in [Ca2+] within Intracellular Organelles During Ischemia-Reperfusion
Mitochondria and the ER play critical roles in neuronal Ca2+ homeostasis
(Berridge et al., 2000; Berridge et al., 2003; Gleichmann and Mattson, 2011; Stutzmann
and Mattson, 2011).

Not surprisingly, ischemia-reperfusion dramatically alters Ca2+

uptake and release from these intracellular organelles.
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Dysfunction of normal Ca2+

signaling from mitochondria and the ER is likely an important component of the dynamic
and pathological changes in [Ca2+]i following ischemia.
Neuronal mitochondria can serve as a sink for pathological Ca2+ overload
(Nicholls, 1985). Micromolar [Ca2+] in the cytoplasm during ischemia provides optimal
conditions for mitochondrial Ca2+ uptake through the mitochondrial uniporter (Colegrove
et al., 2000; Collins et al., 2001). Data from ischemic brain tissue reveal a transient rise
in mitochondrial [Ca2+] ([Ca2+]m) within 10 to 20 min of reperfusion (Dux et al., 1987;
Zaidan and Sims, 1994)).

The timing of the increased [Ca2+]m corresponds to the

decrease in [Ca2+]i immediately following reperfusion, suggesting that mitochondria
sequester Ca2+ from the cytoplasm after ischemia. [Ca2+]m also returns to baseline after
longer periods of reperfusion (Simon et al., 1984; Dux et al., 1987; Zaidan and Sims,
1994) and normal cellular metabolism is restored to neurons (Arai et al., 1986). Similar
to temporal perturbations in [Ca2+]i described above, delayed secondary increases in
[Ca2+]m have been observed in neurons that go on to die after ischemia (Dux et al., 1987;
Zaidan and Sims, 1994). Although the time course of the secondary increase in [Ca2+]m
is variable depending on the model and severity of injury, it reliably precedes histological
evidence of neuronal death. Excessive accumulation of Ca2+ in the mitochondrial matrix
can impair ATP synthesis, increase ROS production, alter mitochondrial membrane
permeability, and cause the release of pro-apoptotic factors (Starkov et al., 2004). Many
of these pathological consequences of mitochondrial Ca2+ overload are involved in the
execution of cell death following ischemia-reperfusion (Neumar, 2000; Starkov et al.,
2004).
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Evidence for the role of disrupted ER Ca2+ homeostasis in post-ischemic neuronal
death primarily comes from studies examining ER Ca2+ uptake and release in ischemic
tissue or in vitro models. Although not well characterized, there are most likely two
distinct phases of ER Ca2+ regulation following ischemia—early accumulation and
subsequent release (Chen et al., 2008). With restoration of energy stores following early
reperfusion, the ER likely sequesters cytoplasmic Ca2+ through activation of the
sacroplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) pump, contributing to the
return to resting [Ca2+]i. Indeed, data support the idea of increased ER Ca2+ filling at
early time points after ischemia in vitro (Chen et al., 2008; Sirabella et al., 2009). At
later time points following ischemia-reperfusion, Ca2+ release from the ER may critically
contribute to neuronal injury and Ca2+-mediated death. This hypothesis is supported by
evidence that: 1) ER Ca2+ release significantly contributes to elevated [Ca2+]i in in vitro
models of ischemia (Mitani et al., 1993; Pisani et al., 2000), 2) preventing Ca2+ release
through ER channels is neuroprotective in vivo (Wei and Perry, 1996; Rao et al., 2000),
and 3) neuronal ER Ca2+ stores in vivo are relatively depleted at later time points
following ischemia-reperfusion (Kohno et al., 1997; Xing et al., 2004).
While disruption of mitochondrial and ER Ca2+ homeostasis can both
independently contribute to neuronal injury following ischemia, coupling of Ca2+
signaling between these organelles suggests that these pathological pathways also
overlap. Close proximity of mitochondria to the ER provides a privileged environment
for high [Ca2+] microdomains (Csordas et al., 2006; Csordas et al., 2010). The physical
and functional connection between mitochondria and the ER may make mitochondria
more prone to Ca2+ overload (Pinton et al., 2008). This effect may potentially explain the
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secondary rise in [Ca2+]m following ischemia-reperfusion, further emphasizing the role of
aberrant ER Ca2+ release in post-ischemic cell death.
Neuroprotective Strategies Targeting [Ca2+]i Following Ischemia
Increased understanding of disrupted neuronal Ca2+ homeostasis has inspired
development of neuroprotective pharmacologic strategies for intervention following
ischemic brain injury (Sahota and Savitz, 2011). The majority of these treatments have
targeted plasma membrane Ca2+ regulatory proteins in an effort to prevent secondary
neuronal Ca2+ overload. Unfortunately, despite promising results in animal models, all
clinical trials of therapeutic agents have proven ineffective in attenuating post-ischemic
neuronal death (Roine et al., 1990; Brain Resuscitation Clinical Trial II Study Group,
1991; Calle et al., 1993; Auriel and Bornstein, 2010; Mongardon et al., 2011; Sahota and
Savitz, 2011). Thus, there is an obvious need for improved therapies and molecular
targets for intervention following ischemia-reperfusion. Based on the data presented
above, we propose that targeting pathological ER Ca2+ release may provide an effective
strategy for neuroprotection by preventing both ER Ca2+ depletion and secondary [Ca2+]i
and [Ca2+]m overload in post-ischemic neurons.

Role of Calpain in Post-ischemic Neuronal Death
One of the downstream effects of elevated [Ca2+]i in ischemic brain tissue is
pathological activation of proteases (Kristian and Siesjo, 1998; Neumar, 2000;
Szydlowska and Tymianski, 2010). Proteolysis is an important component of cell death
pathways and substantial evidence exists to support the role of protease activation in
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post-ischemic neurodegeneration (Bevers and Neumar, 2008; Nakka et al., 2008). Here,
we will explore the role of the Ca2+-dependent calpain family of proteases in mediating
neuronal death after ischemia-reperfusion.
Calpain Activation and Function
Calpains—calcium-dependent proteases with papain-like activity—are cysteine
proteases typically thought to be directly and reversibly activated by Ca2+. There are 15
identified members of the calpain family of proteases, a subset of which are expressed in
brain (Bevers and Neumar, 2008). Of the calpain isoforms found in the brain, the calpain
catalytic subunit isoforms 1 and 2 are the most ubiquitous and best characterized. These
cytoplasmic calpains were initially named µ- and m-calpain respectively based on their
[Ca2+] requirements for activation determined from in vitro assays (Goll et al., 2003).
Physiologically, the difference in Ca2+ sensitivity of these isoforms is likely served by
different subcellular localizations of calpains 1 and 2. Traditionally, calpain 1 is believed
to be diffuse throughout the cytoplasm and often associated with cytoskeletal elements
(Goll et al., 2003; Bevers and Neumar, 2008), whereas calpain 2 has predominately been
localized to membranes and sites of Ca2+ entry into the cytoplasm (Hood et al., 2003;
Hood et al., 2004; Samanta et al., 2007; Leloup et al., 2010). Calpain activity is regulated
by its endogenous inhibitor, calpastatin (Goll et al., 2003). Under normal conditions, the
calpain-calpastatin system plays an important role in physiological neuronal processes
including signal transduction, neurite growth, and synaptic remodeling (Goll et al., 2003;
Bevers and Neumar, 2008).
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Calpain proteolysis of substrates is limited and site-specific. There have been
substantial efforts to determine or predict primary amino acid sequences preferentially
targeted by calpain however, no consensus sequences have been identified (Tompa et al.,
2004; Cuerrier et al., 2005). More likely, calpain cleaves substrates via recognition of
secondary or tertiary protein structure, making it difficult to identify de novo calpain
substrates and their precise cleavage sites. Directed calpain proteolysis generally alters
rather than eliminates substrate function.

Unlike many other proteases, calpain

proteolysis does not strictly lead to substrate degradation, and instead can mediate
complex physiological and pathological signaling processes.
Role of Calpain in Ischemic Brain Injury
Data collected over the past 2 decades have linked both the initiation and
execution of ischemic cell death in vivo to the calpain family of proteases. As increased
[Ca2+]i directly activates calpain, temporal evidence of calpain activation in ischemic
brain tissue closely mirrors that of the bimodal rises in [Ca2+]i (Saido et al., 1993;
Roberts-Lewis et al., 1994; Neumar et al., 1996; Yamashima et al., 1996; Bartus et al.,
1998; Neumar et al., 2001; Zhang et al., 2002; Yamashima et al., 2003). Importantly,
pathological calpain activity identified in these studies was localized to selectively
vulnerable neuron populations. Pharmacologic inhibition of calpains before (Lee et al.,
1991; Rami and Krieglstein, 1993; Yokota et al., 1999) or after global brain ischemia (Li
et al., 1998; Frederick et al., 2008) has been effective in attenuating post-ischemic
neuronal death.

Additionally, genetic approaches to calpain inhibition, either by

overexpression of calpastatin (Higuchi et al., 2005) or knockdown of specific calpain
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isoforms (Bevers et al., 2010), have been neuroprotective in models of excitotoxic and
ischemic brain injury. Together, these data suggest that calpain plays a causal role in
mediating neuronal death following ischemia-reperfusion.
Calpain Proteolysis of Ca2+ Regulatory Proteins
Due to the numerous and diverse cellular substrates for proteolysis, there are
potentially multiple mechanisms by which calpain can initiate or execute neuronal death
following ischemia-reperfusion. One particularly compelling model for calpain-mediated
cell death in ischemic brain injury is calpain proteolysis of Ca2+ regulatory proteins
(Bevers and Neumar, 2008). As calpain proteolysis typically alters substrate function,
cleavage of Ca2+ regulatory proteins provides a unique pathway through which calpain
may increase [Ca2+]i, thereby further increasing calpain activity.
A number of different Ca2+ regulatory proteins are known substrates for calpain
(Table 1.1). In most instances, the functional consequences of proteolysis on substrate
function have been investigated. Cleavage of some of these substrates has been observed
in ischemic brain tissue, whereas others are only putative targets for calpain-mediated
proteolysis following ischemia-reperfusion.
I. Ca2+ extrusion mechanisms targeted by calpain
Calpain can cleave several Ca2+ pumps and transporters.

Evidence from

excitotoxic and ischemic injury models provide evidence of calpain cleavage of both the
plasma membrane Ca2+-ATPase (PMCA) (Pottorf et al., 2006; Ferragamo et al., 2009)
and SERCA (Parsons et al., 1999; French et al., 2006). Proteolysis of PMCA and
SERCA lead to a loss of Ca2+ pump activity and accumulation of Ca2+ in the cytoplasm.
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Similarly, calpain proteolysis of NCX eliminates Ca2+ transport function (Bano et al.,
2005; Samanta et al., 2009), which increases [Ca2+]i in post-ischemic neurons (Bano et
al., 2005). Proteolysis of these substrates may contribute individually or in concert to the
delayed secondary rise in [Ca2+]i following ischemia-reperfusion.
II. Ca2+-permeable ion channels cleaved by calpain
Two ion channels on the plasma membrane are known calpain substrates—L-type
Ca2+ channel and NMDA receptor. Proteolysis of L-type Ca2+ channels increases channel
open probability (Po), likely increasing [Ca2+]i (De Jongh et al., 1994; Wei et al., 1994;
Hell et al., 1996). The NR2 subunit of NMDA receptors is the specific substrate for
calpain and has been shown to be cleaved following excitotoxic injury (Guttmann et al.,
2002; Simpkins et al., 2003). The functional consequence of NMDA receptor proteolysis
is unclear, although the cleaved forms of the channel remain on the plasma membrane
and may contribute to excitotoxicity through altered electrophysiological properties or
interactions with signaling molecules (Simpkins et al., 2003; Dong et al., 2006).
Additionally, calpain cleaves two ER Ca2+ release channels—Ryanodine receptor
(RyR) and InsP3R1. Calpain-mediated proteolysis of RyR impairs channel inactivation
and increases Po (Rardon et al., 1990), which may increase [Ca2+]i. Calpain cleavage of
InsP3R1 has been observed in vitro and in vivo (Magnusson et al., 1993; Wojcikiewicz
and Oberdorf, 1996; Igwe and Filla, 1997; Diaz and Bourguignon, 2000). However, the
functional consequences of calpain proteolysis on electrophysiological properties of
InsP3R1 and the potential impact on [Ca2+]i following ischemia-reperfusion were
previously unknown.
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Dysfunctional Ca2+-permeable ion channels generated by calpain proteolysis may
be central players in disruption of neuronal Ca2+ homeostasis following ischemia.
Unfortunately, blocking Ca2+ entry through voltage-gated Ca2+ channels and NMDA
receptors has not been a clinically effective strategy for neuroprotection in ischemic brain
injury (Mongardon et al., 2011; Sahota and Savitz, 2011). Instead, blocking aberrant ER
Ca2+ release following ischemia-reperfusion may be an appealing target for future
interventional strategies.
Role of InsP3R1 Proteolysis in Ischemic Brain Injury
Prior to the investigations presented in this dissertation, the significance of calpain
proteolysis of InsP3R1 was unclear and the role of InsP3R-mediated Ca2+ signaling in
post-ischemic neuronal death was incompletely understood. We hypothesized that both
are potentially important factors in either the initiation or execution of neuronal death
following ischemia-reperfusion. In spite of our previously limited understanding of the
role of InsP3R in ischemic brain injury, the molecular structure and physiological
functions of InsP3R have been well studied. Foskett et al. (2007) provides an excellent
and extensive review of the InsP3R Ca2+ release channel. The overview presented here
provides a brief survey of the literature particularly relevant to this thesis.
Structure and Gating of InsP3R
InsP3R is a ubiquitous intracellular Ca2+ release channel predominately located on
the ER membrane. The large InsP3R protein (2749 amino acids in rat) includes an
amino-terminal InsP3 ligand-binding domain, a large, central coupling (modulatory)
domain, and 6 transmembrane domains in the carboxyl-terminal region (Figure 1.1)
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(Taylor et al., 2004; Bezprozvanny, 2005; Foskett et al., 2007).

Within the

transmembrane domains, helices 5 and 6 form the basic pore structure of the ion channel
and confer selectivity (Taylor et al., 2004; Foskett et al., 2007). InsP3Rs function as
tetrameric channels. The carboxyl-terminal portion of InsP3R is important for both
subunit oligomerization and localization of the channel to the ER membrane (Sayers et
al., 1997; Galvan et al., 1999; Parker et al., 2004).
InsP3R activity is regulated by a number of different ligands, the most important
of which are InsP3 and Ca2+ (Foskett et al., 2007). Both of these ligands are required for
appreciable channel activity, making InsP3R a molecular coincidence detector. InsP3, a
second messenger generated by phospholipase C hydrolysis of phosphatidylinositol 4,5bisphosphate, connects activation of Gq-coupled receptors on the plasma membrane with
InsP3R channel opening (Streb et al., 1983). InsP3 binding to the ligand-binding domain
of InsP3R is important for both channel gating and modulating InsP3R sensitivity to its
other principal ligand, Ca2+ (Foskett et al., 2007). Data suggest that Ca2+ binds to InsP3R
at multiple sites with different affinities to regulate InsP3-dependent Ca2+ activation, and
InsP3-dependent and independent Ca2+ inhibition, although the precise binding sites are
unclear (Foskett et al., 2010). Ca2+ regulation of InsP3R is biphasic, with non-optimal
[Ca2+]i leading to decreased channel Po. This modulation by InsP3R’s physiologically
permeant ion provides important positive and negative feedback for InsP3R-mediated
Ca2+ signaling (Foskett et al., 2007; Foskett et al., 2010). Upon binding of optimal
concentrations of both ligands, the InsP3R channel gate opens and Ca2+ diffuses down its
concentration gradient into the cytoplasm.
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The transduction mechanism by which InsP3 and Ca2+ binding opens the gate is
poorly understood. Initial studies suggested that InsP3 binding induces a conformational
change in the channel, which opens the gate (Mignery and Sudhof, 1990). More recent
evidence has proposed that an interaction between the ligand-binding domain and
carboxyl-terminus of InsP3R mechanically transmits the signal for gating (Schug and
Joseph, 2006; Chan et al., 2010; Yamazaki et al., 2010). Interestingly however, deletion
of large portions of the amino-terminus of InsP3R upstream of the transmembrane
domains or through the fourth transmembrane helix generates a channel with constitutive
activity (Ramos-Franco et al., 1999; Nakayama et al., 2004). This suggests a different or
perhaps more complex model of gating and channel regulation than initially predicted.
Expression and Function of InsP3R in Neurons
There are 3 distinct isoforms of InsP3Rs, types 1, 2 and 3 (Foskett et al., 2007).
Of these, InsP3R1 is the most ubiquitous and abundant isoform expressed in the brain
(Furuichi et al., 1993; Sharp et al., 1993). Immunohistochemical labeling of brain tissue
reveals heterogeneous expression patterns of InsP3R across neuronal populations and
within cells. Interestingly, the level of InsP3R expression in neurons positively correlates
with vulnerability to ischemic injury.

For example, within hippocampus, InsP3R

expression is relatively high in CA1 pyramidal neurons and low in both CA3 pyramidal
neurons and granule cells in the dentate gyrus (Sharp et al., 1993). Similarly, InsP3R
expression in cerebellum is predominately localized to Purkinje neurons (Sharp et al.,
1993).

This expression pattern suggests a possible role for InsP3R-mediated Ca2+
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signaling in disruption of Ca2+ homeostasis and neuronal injury following ischemiareperfusion.
As the ER is the major storage organelle for Ca2+, InsP3Rs are vital to intracellular
Ca2+ signaling in neurons (Stutzmann and Mattson, 2011). Ca2+ release through InsP3R
has diverse temporal and spatial signaling properties. Stimulation of InsP3R can evoke
small, localized elevations in [Ca2+]i through activation of a only a few channels, or larger
waves of increased [Ca2+]i that propagate through the cell by activating clusters of
neighboring InsP3Rs (Foskett et al., 2007). Differential expression patterns of InsP3R in
somatic, dendritic, and synaptic neuronal compartments leads to even more complex Ca2+
signaling patterns that play important roles in neuronal excitability, gene transcription,
and synaptic plasticity (Bardo et al., 2006; Stutzmann and Mattson, 2011).
InsP3R-mediated Ca2+ Signaling in Neuropathology
In addition to their fundamental importance to neuronal physiology, InsP3Rs also
contribute to pathological Ca2+ signaling and neurodegeneration (Verkhratsky and
Toescu, 2003; Foskett, 2010). Reports that cells deficient in InsP3Rs were resistant to
apoptosis (Jayaraman and Marks, 1997; Sugawara et al., 1997) initially suggested a role
for InsP3R-mediated Ca2+ signaling in cell death. Subsequent studies have shown that
allosteric modulation of InsP3R channel function induces aberrant neuronal Ca2+
signaling in a variety of neurodegenerative diseases, including Alzheimer’s disease
(Leissring et al., 1999a; Leissring et al., 1999b; Stutzmann et al., 2004; Cheung et al.,
2008; Cheung et al., 2010), Huntington’s disease (Tang et al., 2003; Tang et al., 2005;
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Higo et al., 2010), spinocerebellar ataxias (Liu et al., 2009), and ischemia (Boehning et
al., 2003; Beresewicz et al., 2006).
In models of ischemic brain injury, data suggest additional changes in InsP3R
function that appear unrelated to the characterized allosteric modulation of the channel.
Specifically, decreased InsP3 binding (Jorgensen et al., 1991; Nagasawa and Kogure,
1991; Dahl et al., 2000) and decreased InsP3-induced Ca2+ release (Nagata et al., 1999)
have been observed in vivo following ischemia-reperfusion. These changes are not
associated with a decrease in InsP3R protein levels (Dahl et al., 2000). Proteolytic
cleavage of the cytosolic amino-terminus of InsP3R could explain these observations.
Proteolysis of InsP3R1
InsP3R1 is a target for proteolysis by both caspase and calpain cysteine proteases.
Cleavage of InsP3R1 by either protease generates a stable ~95 kDa carboxyl-terminal
fragment that contains the transmembrane domains and channel pore.

While the

functional effects of InsP3R1 proteolysis by calpain were previously unexamined, studies
of the caspase-cleaved form of the channel provided some initial insights.
Caspase-3 cleaves InsP3R1 at a highly conserved consensus sequence within the
coupling domain (Figure 1.1) (Hirota et al., 1999), and InsP3R1 has been identified as a
substrate for caspase-3 during apoptosis (Hirota et al., 1999; Diaz and Bourguignon,
2000; Haug et al., 2000; Verbert et al., 2008). Of the 3 InsP3R isoforms, only the type 1
receptor contains the DEVD sequence for caspase-3 recognition and proteolysis (Hirota
et al., 1999). While activation of caspase-3 is traditionally considered an executioner of
apoptosis rather than an initiator, there is evidence that caspase-cleavage of InsP3R1 is
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required for apoptosis (Assefa et al., 2004) and is an early event in the cell death cascade
(Haug et al., 2000).

Caspase-3-mediated proteolysis of InsP3R1 in cells results in

decreased InsP3 binding (Diaz and Bourguignon, 2000) and diminished InsP3-induced
Ca2+ release (Hirota et al., 1999; Diaz and Bourguignon, 2000), while preserving
structural and functional integrity of the channel domain (Hirota et al., 1999). These
studies suggested that caspase-proteolysis of InsP3R1 sensitizes cells to apopotosis by
disruption of Ca2+ homeostasis.
To directly examine the role of caspase-cleaved InsP3R1 in cell death, previous
studies have expressed a truncated, recombinant form of InsP3R1 that corresponds to the
carboxyl-terminal channel fragment derived from caspase-3 proteolysis. Expression of
caspase-cleaved InsP3R1 in these studies resulted in decreased ER releasable Ca2+
(Nakayama et al., 2004; Verbert et al., 2008), increased ER Ca2+ leak rate (Verbert et al.,
2008), and slowed ER Ca2+ uptake (Verbert et al., 2008). These data suggest that
caspase-3 proteolysis of InsP3R1 generates a leaky channel that decreases ER Ca2+
buffering capacity.

Additionally, expression of caspase-cleaved InsP3R1 impaired

normal ER Ca2+ signaling (Verbert et al., 2008) and increased the rate of apoptosis
following injury (Assefa et al., 2004). Together, these data support a role for InsP3R1
proteolysis in disruption of Ca2+ homeostasis and cell death.
InsP3R1 is also a known substrate for calpain, which sequentially cleaves the
channel into 200, 130, and 95 kDa carboxyl-terminal fragments (Magnusson et al., 1993;
Igwe and Filla, 1997). While the stable predominant 95 kDa calpain-derived fragment is
reported to be similar in size to the caspase-derived fragment, the cleavage sites are
different. To the best of our knowledge, there was no published description of the
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functional consequences of calpain cleavage of InsP3R1 prior to our investigation.
However, based on studies of the caspase-cleaved channel, we hypothesized that calpainmediated cleavage of InsP3R1 disrupts normal channel gating, and that this dysregulation
increases ER Ca2+ release and limits ER Ca2+ buffering capacity. We further speculated
that InsP3R1 proteolysis by calpain would significantly contribute to delayed [Ca2+]i and
[Ca2+]m overload and secondary activation of calpain following ischemia-reperfusion.
Rationale
The molecular injury mechanisms that result in neurodegeneration after ischemic
brain injury are incompletely understood. However, disruption of Ca2+ homeostasis and
pathological calpain activation are key components of post-ischemic neuronal death.
InsP3R1, as both a Ca2+ regulatory protein and proteolytic target of calpain, is critically
poised to execute cell death pathways.
At the onset of this investigation, we hypothesized that InsP3R1 proteolysis by
calpain irreversibly disrupts cellular Ca2+ homeostasis and that Ca2+ signaling through the
cleaved channel triggers post-ischemic neuronal death (Figure 1.2). Based on earlier
studies of InsP3R1 proteolysis, we speculated that calpain cleavage generates a channel
with InsP3-independent gating that increases ER Ca2+ leak and impairs intracellular Ca2+
buffering. These alterations in normal InsP3R1-mediated Ca2+ signaling could lead to
neuronal Ca2+ overload and death by shifting Ca2+ from the ER lumen to the cytoplasm
and mitochondria. Increases in [Ca2+]i may initiate a positive feedback loop leading to
augmented calpain activity. Alternativey, increased [Ca2+]m could amplify intrinsic cell
death pathways through release of pro-apoptotic factors.
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Thus, InsP3R1 proteolysis

potentially represents a pivotal transition to irreversible neuronal injury.

If calpain

proteolysis of InsP3R1 plays a causal role in post-ischemic neuronal death, then blocking
the cleaved channel could emerge as a novel therapeutic strategy. The experiments
presented in this dissertation serve to elucidate the neuropathologic role of InsP3R1
proteolysis by calpain.
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Figure 1.1

Figure 1.1 Domain structure of InsP3R1
The InsP3R1 protein, depicted as a linear amino acid sequence, contains 3 major domains. The aminoterminal region is the InsP3 ligand-binding domain (red). The central coupling domain (yellow) contains
the DEVD sequence for caspase-3 cleavage (arrow). The channel domain (green) of InsP3R1 is located
near the carboxyl-terminus of the protein and consists of 6 transmembrane domains (grey). Mutation of
D2550 (to A or N; arrow) in the pore forming region eliminates Ca2+ permeability of the channel.
Residues are numbered according to the rat type 1 SI+, SII+, SIII- sequence (protein accession no.
NP_001007236.1; Adapted from Foskett et al., 2007).
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Figure 1.2

Figure 1.2 Neuropathologic role of InsP3R1 proteolysis
Schematic representation of known and hypothesized molecular cascades initiated by ischemic brain injury.
(A) Ischemic depolarization of neurons causes Ca2+ influx, resulting in an initial increase in [Ca2+]i, and
subsequent calpain activation. We hypothesize that this early calpain activity results in proteolysis of
InsP3R1. (B) We additionally hypothesize that InsP3R1 proteolysis generates a dysregulated channel that
leaks Ca2+ from the ER, which increases [Ca2+]i. Sustained elevations in [Ca2+]i can lead to pathological
activation of calpain, or mitochondrial Ca2+ overload, permeability transition (MPT), and release of proapoptotic factors (green). Together, these events may be responsible for delayed neuronal death following
ischemia-reperfusion.
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SUMMARY

The type 1 inositol 1,4,5-trisphosphate receptor (InsP3R1) is a ubiquitous intracellular
Ca2+ release channel that is vital to intracellular Ca2+ signaling. InsP3R1 is a proteolytic
target of calpain, which cleaves the channel to form a 95 kDa carboxyl-terminal fragment
that includes the transmembrane domains, which contain the ion pore. However, the
functional consequences of calpain proteolysis on channel behavior and Ca2+ homeostasis
are unknown. In the present study, we have identified a unique calpain cleavage site in
InsP3R1, and utilized a recombinant truncated form of the channel (capn-InsP3R1)
corresponding to the stable, carboxyl-terminal fragment to examine the functional
consequences of channel proteolysis.

Single-channel recordings of capn-InsP3R1

revealed InsP3-independent gating and high open probability (Po) under optimal
cytoplasmic Ca2+ concentration ([Ca2+]i) conditions. However, some [Ca2+]i regulation of
the cleaved channel remained, with a lower Po in sub-optimal and inhibitory [Ca2+]i.
Expression of capn-InsP3R1 in N2a cells reduced the Ca2+ content of ionomycinreleasable intracellular stores and decreased endoplasmic reticulum Ca2+ loading
compared with control cells expressing full-length InsP3R1. Using a cleavage-specific
antibody, we identified calpain-cleaved InsP3R1 in selectively vulnerable cerebellar
Purkinje neurons following in vivo cardiac arrest. These findings indicate that calpain
proteolysis of InsP3R1 generates a dysregulated channel that disrupts cellular Ca2+
homeostasis. Furthermore, our results demonstrate that calpain cleaves InsP3R1 in a
clinically relevant injury model, suggesting that Ca2+ leak through the proteolyzed
channel may act as a feed-forward mechanism to enhance cell death.
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INTRODUCTION
Changes in cytoplasmic free Ca2+ concentration ([Ca2+]i) act as a ubiquitous
signaling system that is essential to proper neuronal function and survival. Conversely,
disrupted [Ca2+]i can serve as a trigger for cell death (Berridge et al., 2000; Orrenius et
al., 2003). In particular, compelling evidence suggests that disruption of cellular Ca2+
homeostasis, caused in part by dysfunction of Ca2+ regulatory proteins, plays a causal
role in both acute brain injury and chronic neurodegenerative diseases (Bevers and
Neumar, 2008).
The inositol 1,4,5-trisphosphate receptor (InsP3R), a ubiquitous intracellular Ca2+
release channel located on the endoplasmic reticulum (ER) membrane, may be an
important component of the pathologic cascades leading to disrupted Ca2+ homeostasis in
many disease states. Cells deficient in InsP3Rs are resistant to apoptosis (Jayaraman and
Marks, 1997; Sugawara et al., 1997) suggesting that InsP3R mediated Ca2+ signaling
plays a mechanistic role in cell death. Altered InsP3R channel function induces aberrant
neuronal Ca2+ signaling in a variety of neurodegenerative diseases including Alzheimer’s
disease (Leissring et al., 1999a; Leissring et al., 1999b), Huntington’s disease (Tang et
al., 2003) and ischemia (Beresewicz et al., 2006). Observations in brain ischemia models
also suggest altered InsP3R function, specifically, decreased InsP3 binding (Nagasawa
and Kogure, 1991; Dahl et al., 2000), decreased InsP3-induced Ca2+ release (Nagata et al.,
1999) and depletion of releasable Ca2+ stores (Zaidan and Sims, 1994; Kohno et al.,
1997). Proteolytic cleavage of InsP3R could explain these observations.
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The type 1 InsP3R (InsP3R1), the predominant neuronal isoform, is a substrate for
both the caspase and calpain families of cysteine proteases (Foskett et al., 2007). These
proteases are indirectly (caspase-3) and directly (calpain) activated by Ca2+ and are
known to play a central role in apoptotic and necrotic cell death pathways (Wang, 2000).
Proteolytic activity of these enzymes is limited and site specific, typically altering rather
than eliminating substrate function. In the case of Ca2+ regulatory proteins, this may
initiate a positive feedback loop that further increases protease activation via increases in
[Ca2+]i.
Caspase-3 or calpain cleavage of InsP3R1 generates carboxyl-terminal fragments
of approximately 95 kDa (Hirota et al., 1999). Caspase-3 cleaves InsP3R1 at a highly
conserved DEVD consensus sequence within the coupling domain (Hirota et al., 1999)
(Figure 2.1A). Caspase-mediated proteolysis of the channel has been observed in several
models of apoptosis (Hirota et al., 1999; Diaz and Bourguignon, 2000; Haug et al., 2000).
Previous studies have demonstrated altered ER Ca2+ homeostasis in cell lines expressing
a recombinant caspase-derived carboxyl-terminal fragment of InsP3R1, suggesting that
cleavage generates an unregulated channel that may leak Ca2+ from intracellular stores
(Assefa et al., 2004; Nakayama et al., 2004; Verbert et al., 2008). InsP3R1 is also a
substrate for calpain, which sequentially cleaves the protein into 200, 130 and 95 kDa
carboxyl-terminal fragments (Magnusson et al., 1993; Wojcikiewicz and Oberdorf, 1996;
Igwe and Filla, 1997). However the specific calpain cleavage site that generates the
stable 95 kDa fragment has not been established, and the functional consequences of
proteolysis on channel activity are unknown. We hypothesized that calpain-mediated
proteolysis, which removes the amino-terminal ligand binding domain and a large portion
29

of the regulatory domain, generates a channel with InsP3-independent gating that leaks
Ca2+ from ER stores.
In the present study, we have identified the unique calpain-cleavage site of
InsP3R1 and investigated the electrophysiological and functional properties of the
truncated carboxyl-terminal channel. Using a combination of single-channel nuclear
patch clamp electrophysiology and single-cell Ca2+ imaging, we have determined that the
cleaved channel is constitutively active in the absence of InsP3, although its gating retains
sensitivity to [Ca2+]i. Constitutive channel activity accounts for an observed reduction in
the Ca2+ content of the ER lumen in cells expressing recombinant calpain-cleaved InsP3R1.

Importantly, we provide evidence of calpain-mediated proteolysis of InsP3R1 in an

in vivo model of ischemic brain injury. These data highlight the important functional
consequences of calpain-mediated channel proteolysis, which may critically disrupt
intracellular Ca2+ homeostasis, particularly under pathologic conditions where other Ca2+
regulatory proteins are also compromised.
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EXPERIMENTAL PROCEDURES
Materials—Unless otherwise noted, all chemical reagents were purchased from
Sigma-Aldrich.
Antibodies—The anti-InsP3R1 polyclonal antibody targeted against the 20
carboxyl-terminal residues of rat InsP3R1 was generously provided by Dr. Suresh Joseph
(Thomas Jefferson University) (Joseph and Samanta, 1993). The antibody to calpaincleaved spectrin (Ab38) was generously provided by Dr. Robert Siman (University of
Pennsylvania). Anti-calreticulin (CRT) polyclonal antibody was purchased from Thermo
Scientific Pierce Antibodies (PA3-900). Alexa-488 conjugated secondary antibody used
for immunofluorescence was purchased from Invitrogen. The antibody against calpaincleaved InsP3R1 (Ab2054) was generated against the peptide ASAATRKAC and is
described in the Results section.
Cerebellar

Microsome

Isolation—Male

Long-Evans

rats

were

deeply

anesthetized with pentobarbital (200 mg/kg) and decapitated. The brain was extracted,
and the cerebellum dissected and homogenized in cold MSHE buffer (in mM): 220
mannitol, 70 sucrose, 2 K-HEPES (pH 7.4), 0.5 EGTA with 0.1% fatty-acid free bovine
serum albumin (BSA) and protease inhibitor cocktail. The homogenate was centrifuged
at 650 x g for 10 min at 4° C to remove nuclei (P1). The supernatant from the preceding
fraction (S1) was centrifuged again at 8,000 X g for 10 min at 4° C to separate cytoplasm
and microsomes from mitochondria and synaptosomes. The remaining supernatant (S2)
was centrifuged at 100,000 X g for 1 h in a micro-ultracentrifuge (ThermoFisher
Scientific). The pellet from the final spin (P3) containing microsomes was resuspended
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in either MSHE buffer without BSA for western blot or digest buffer for subsequent in
vitro digest, snap frozen and stored at -20° C.
InsP3R1 Peptide Generation—The amino acid sequences of rat InsP3R1 from
residues 1582 to 1932 or from residues 1932 to 2257 were fused to an amino-terminal
glutathione S-transferase (GST) using the linker sequence LEVLFQGP, and cloned into
pGEX expression vectors. The fusion protein was grown in BL21 E. coli and purified
using Glutathione Sepharose 4B (GE Healthcare). The GST tag was removed from the
InsP3R1 1582-1932aa peptide following purification using PreScission Protease, which
recognizes the sequence LEVLFQ/GP and cleaves between the Q and G residues (GE
Healthcare).
In Vitro Caspase-3 and Calpain 1 Digests of Microsomes and InsP3R1 Peptide—
For in vitro caspase-3 digest of cerebellar microsomes, freshly isolated microsomes were
resuspended in lysis buffer (in mM: 50 Tris-HCl (pH 7.4), 5 EDTA, 1 DTT (Fisher) with
1% Triton X-100) and incubated at 4° C for 90 min prior to snap freezing.

For

subsequent digest, lysed microsomes were diluted to 1 µg/µl in digest buffer (in mM: 100
Tris-HCl (pH 7.4), 2 EDTA, and 20 DTT). Samples were preincubated with 1 µM
calpastatin peptide (CAST; EMD Biosciences) to inhibit endogenous calpain activity and
then digested with recombinant active human caspase-3 (0.05 units/µl; Millipore) for 4 h
at 37° C. Loading buffer was added to the digest to stop the reaction.
For in vitro calpain digest of cerebellar microsomes, freshly isolated microsomes
were resuspended in a modified digest buffer (in mM: 25 HEPES (pH 7.4), 250 sucrose,
1 EDTA) and snap frozen. For subsequent digest, microsomes were diluted to 1 µg/µl in
complete digest buffer (in mM: 25 HEPES (pH 7.4), 250 sucrose, 1 EDTA, 2 DTT, and 2
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CaCl2). Samples were preincubated with 1 mM Z-VAD-FMK (Promega) to inhibit
endogenous caspase activity, and then digested with 0.5 µM calpain 1 (µ-calpain) from
human erythrocytes (EMD Biosciences) at 4° C for various times. Loading buffer was
added to the digest to stop the reaction.
For in vitro calpain digest of the GST-InsP3R1 fusion peptides, purified peptide was
diluted in digest buffer (in mM: 25 HEPES (pH 7.5), 250 NaCl, 2 DTT, 1 CaCl2 with
1.2% CHAPS). Samples were digested with 0.1 µM calpain 1 at 4° C for various times.
Adding loading buffer to the digest terminated the reaction.
Edman N-terminal Sequencing to Determine Cleavage Site—N-terminal
automated Edman sequencing was performed on an Applied Biosystems 494 Protein
Sequencer using standard programs and reagents (Wistar Institute, Proteomics Core
Facility). Samples were excised from stained PVDF membranes, wetted with MeOH and
sonicated in MilliQ water for 5 min. Samples were then removed and placed in MeOH
prior to loading into the upper sample cartridge unit. The cartridge was assembled, the
sample was dried with argon, inserted into the instrument, and processed with a standard
pulsed liquid method for 8 cycles.
Plasmids—The pIRES2-EGFP (Clontech) expression vector for wild type (wt) rat
InsP3R1 was previously generated (Li et al., 2007). To construct the expression vector
for calpain-cleaved InsP3R1 (capn-InsP3R1; Figure 2.3A), we amplified the 3’-portion of
rat InsP3R1 cDNA sequence corresponding to the stable carboxyl-terminal fragment of
the channel generated by calpain proteolysis (2.6 kb) using primers 5’—
GCGAATTCATGGCATCTGCTGCCACCAG—3’

and

5’—

GTCTCTAGAAAATGTACTTAAGCGCACAT—3’ (underlined regions indicate EcoRI
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and XbaI restriction sites).

PCR was performed using PfuTurbo DNA polymerase

(Stratagene) and subcloned the capn-InsP3R1 PCR product into the pIRES2-EGFP
expression vector using EcoRI and XbaI restriction sites. EGFP was expressed with
InsP3R1 constructs from a single bicistronic mRNA using an internal ribosome entry site
in the pIRES2-EGFP expression vector.
Cell Culture, DNA Transfection and Lysate Preparation—Neuro-2A (N2a) cells
were cultured in Minimum Essential Medium (Invitrogen) supplemented with 10% fetal
bovine serum and maintained at 37° C in a humidified incubator with 5% CO2. N2a cells
were grown on polystyrene multiwell plates (Western blot), polystyrene tissue culture
flasks (electrophysiology), or 20 x 50 mm glass coverslips (single-cell Ca2+ imaging) and
transfected using Lipofectamine 2000 (Invitrogen).

For Western blot, cells were

harvested by trypsinization and resuspended in homogenization buffer (in mM: 50 Tris,
150 NaCl, 2 EGTA) and sonicated. Lysates were treated with SDS loading buffer, boiled
and analyzed on SDS-PAGE gels. Where indicated, capn-InsP3R1 transfected cells were
solubilized and denatured in buffer supplemented with 5 M urea or 1% SDS.
Single-Channel Electrophysiology—Nuclei from N2a cells were isolated 24 h posttransfection as previously described (White et al., 2005; Ionescu et al., 2006; Cheung et
al., 2008; Cheung et al., 2010). Briefly, nuclei were mechanically isolated, and plated
onto a glass-bottomed dish with standard bath solution (in mM: 140 KCl, 10 Hepes, 0.5
BAPTA and 0.192 CaCl2 (free [Ca2+] ≈ 70 nM), pH 7.1). The pipette solution contained
(in mM): 140 KCl, 0.5 ATP, 10 Hepes pH 7.3, and 0.5 dibromo-BAPTA and 0.3 CaCl2
(free [Ca2+] ≈ 2 µM), 0.5 BAPTA and 0.192 CaCl2 (free [Ca2+] ≈ 70 nM), or 0.5 HEDTA
and 0.43 CaCl2 (free [Ca2+] ≈ 25 µM). Where indicated, 10 µM InsP3 with or without
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100 µg/ml heparin were included in the pipette solution. Data were acquired at room
temperature using an Axopatch 200A amplifier (Axon Instruments) and analyzed as
previously described (Cheung et al., 2010).
Single-Cell Ca2+ Imaging—To measure [Ca2+]i, N2a cells were plated onto glasscoverslips (Warner Instruments) and transfected.

Six h post-transfection, cells on

coverslips were secured in a perfusion chamber, and mounted on the stage of an inverted
microscope (Nikon Eclipse TE2000). Cells were loaded with Fura-2-AM (Molecular
Probes; 2.5 µM) for 30 min at room temperature in Ca2+-containing extracellular solution
(in mM: 137 NaCl, 2 KCl, 2 CaCl2, 10 HEPES, pH 7.3) supplemented with 1% BSA.
Fura-2 was alternately illuminated at 340/380 nm, and fluorescence intensity filtered at
510 nm. Data were collected and recorded as described previously (White et al., 2005;
Cheung et al., 2008). Cells were perfused with 2 mM Ca2+ extracellular solution to
establish baseline [Ca2+]i before ionomycin (Invitrogen; 2 µM) was applied in 0-Ca2+
extracellular solution (in mM: 137 NaCl, 2 KCl, 0.5 EDTA, 0.5 EGTA, 10 HEPES, pH
7.3) to measure Ca2+ release from intracellular stores. At the end of the experiment, Mn2+
was used to quench Fura-2 fluorescence (2 mM Ca2+ extracellular solution supplemented
with 10 mM MnCl2 and 10 µM ionomycin). The remaining background fluorescence
following Mn2+ quench was subtracted during analysis.
To measure ER lumenal [Ca2+] ([Ca2+]ER), transfected cells (6 h post-transfection)
were loaded with the low-affinity Ca2+ indicator Mag-Fura-2-AM (Invitrogen; 10 µM)
for 30 min at 37° C in HEPES-HBSS buffer (HBSS solution supplemented with (in mM):
10 HEPES, 4.2 NaHCO3, 1.8 CaCl2, and 0.8 MgCl2, pH 7.3) with 1% BSA. After
loading, cells were permeabilized with 10 µg/ml digitonin for 2 min in MgATP-free
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cytoplasm-like medium (CLM; in mM: 140 KCl, 20 NaCl, 1 EGTA, 0.375 CaCl2 (final
concentration ≈ 70 nM), 20 PIPES, pH 7.3). Cells were perfused with CLM for 30 min
to wash out digitonin and deplete ER Ca2+ stores. ER store loading was activated by
addition of 1.5 mM MgATP to the perfusate to stimulate SERCA-mediated Ca2+ uptake.
Following filling, the passive ER Ca2+ leak was evaluated by measuring [Ca2+]ER during
exposure to 10 µM cyclopiazonic acid (CPA; Calbiochem) in the absence of MgATP.
Mag-Fura-2 excitation and emission were monitored as described above. Rates for ER
loading and release were calculated by fitting individual single-cell responses using
single exponential functions and determining the mean of those rates.
Changes in [Ca2+]i and [Ca2+]ER are presented as changes in fluorescence ratio.
Dye calibration was achieved by applying experimentally determined constants to the
equation: [Ca2+] = Kd β(R–Rmin)/(Rmax–R).

Macros used for analysis were custom

macros written for IGOR Pro (WaveMetrics).
Cardiac Arrest Model—Male Long-Evans rats weighing 300-350 g (Harlan
Laboratories

Inc.)

were subjected

to

asphyxial

cardiac

arrest

followed

by

cardiopulmonary resuscitation and post-cardiac arrest temperature regulation as
previously described (Katz et al., 1995; Neumar et al., 1995; Che et al., In Press). Rats
were anesthetized, orotracheally intubated and mechanically ventilated. Temperature
was maintained between 37.0 and 37.5° C.

To initiate cardiac arrest, rats were

chemically paralyzed using intravenous vecuronium (2 mg/kg) and asphyxia induced by
discontinuing mechanical ventilation. Cessation of arterial pulse pressure and reduction
of mean arterial pressure to < 20 mmHg was used to confirm circulatory arrest, which
usually occurred within 3-4 min. Following the 7 min asphyxia, mechanical ventilation
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resumed with 100% O2, intravenous epinephrine (0.005 mg/kg) and HCO3 (1.0 mEq/kg)
were administered, and external chest compressions were performed (350-400
compressions/min). Following return of spontaneous circulation, rats were maintained on
mechanical ventilation for 1 h. An intraperitoneal telemetric temperature probe was
surgically implanted in the abdomen (Data Systems International).

Rats were then

extubated and transferred to a computer controlled temperature regulation chamber,
which telemetrically monitored intraperitoneal temperature. Post-cardiac arrest body
temperature was maintained between 36.5 and 37.5° C using software-driven relays
connected to a heat-lamp, water misters and a cooling fan (Colbourne et al., 1996; Che et
al., In Press). This study was approved by the University of Pennsylvania Institutional
Animal Care and Use Committee.
Immunohistochemical Staining of Cerebellum—At indicated time points
following cardiac arrest (24 or 48 h), rats were anesthetized with pentobarbital (200
mg/kg) and transcardially perfused with cold phosphate buffered saline (PBS, pH 7.4)
followed by 4% paraformaldehyde (PFA) in 0.1M phosphate buffer (PB). Brains were
extracted, post-fixed in 4% PFA over-night and cryoprotected using serial incubations in
0.1 M PB containing 10%, 20% and 30% sucrose. Serial sagittal sections through the
cerebellum (40 µm) were cut on a freezing sliding microtome and stored in
cryoprotectant (0.1 M PB with 30% sucrose and 30% glycerol) at -20°C for future use.
Immunohistochemistry to identify calpain-cleaved InsP3R1 (Ab2054) required heatinduced epitope retrieval (HIER).

Cerebellar tissue sections were removed from

cryoprotectant, rinsed in dH2O, and incubated in citrate buffer (10 mM sodium citrate
with 0.05% Tween-20, pH 6.0) at 95°C for 20 min.
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Following HIER, tissue was

removed from heat and rinsed in PBS (pH 7.2). Standard immunohistochemical staining
procedures followed.
Floating cerebellar brain sections were rinsed in PBS (pH 7.2) and blocked using
PBS with 4% normal goat serum and 0.5% Triton X-100. Sections were incubated in
primary antibody (Ab38 or Ab2054) diluted in block solution overnight at 4° C. Sections
were rinsed with PBS and incubated with Alexa 488 fluorescent secondary antibody.
Finally, sections were rinsed with PBS, counterstained with Hoescht (5 µg/ml in PBS) to
label nuclei, mounted on slides and coverslipped under Fluormount-G (Electron
Microscopy Sciences).
For Fluoro-Jade labeling, PFA-fixed sections were mounted onto gelatin-coated
slides and dried. Tissue was treated with 100% ethanol, 70% ethanol and dH2O rinses.
Hydrated tissue was incubated with 0.06% potassium permanganate for 10 min, rinsed
with dH2O, and stained with 0.0004% Fluoro-Jade B (Millipore) in 0.1% acetic acid for
20 min. Stained tissue was rinsed with dH2O, dried at 37°C, dehydrated with xylene and
coversliped using Permount (Fisher Scientific).
Immunofluorescence was studied at 100X using an epifluorescence microscope
(Leica DM4500B).
Analyses and Statistics—Data are presented as the mean ± SEM, and statistical
significance of differences between the means was assessed using either unpaired t-tests
or analysis of variance (ANOVA) for repeated-measures using Barlett’s test for equal
variances and a Bonferroni correction. Differences between means were accepted as
statistically significant at the 95% level (p < 0.05).
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RESULTS
Identifying the calpain-cleavage site of InsP3R1
InsP3R1 is a known substrate of calpain, which sequentially cleaves the protein
into 200, 130, and 95 kDa carboxyl-terminal fragments, with the 95 kDa fragment being
the stable, predominant cleavage product (Figure 2.1B) (Magnusson et al., 1993;
Wojcikiewicz and Oberdorf, 1996; Igwe and Filla, 1997). While the 95 kDa calpainderived fragment is similar in size to the caspase-derived fragment, the cleavage sites are
different. To determine the calpain cleavage site of InsP3R1, we first examined the
relative sizes of the caspase- and calpain-cleaved carboxyl-terminal fragments of InsP3R1
using in vitro digests of rat cerebellar tissue, which is enriched in InsP3R1.

We

performed in vitro digests of cerebellar microsomes with either recombinant,
constitutively active caspase-3 or exogenous calpain 1. A Western blot of the digest
products using a carboxyl-terminal InsP3R1 antibody demonstrated loss of the full-length
protein and generation of stable carboxyl-terminal fragments of approximately 95 kDa
(Figure 2.1C). Shown here for the first time, calpain cleavage of InsP3R1 generates a
slightly smaller fragment than the fragment generated by caspase cleavage.
Caspase cleavage of InsP3R1 is known to occur at the carboxyl-terminal end of
the

1888

DEVD consensus sequence (Figure 2.1A) (Hirota et al., 1999). Based on the

relative sizes of the caspase and calpain InsP3R1 cleavage products, we deduced that the
calpain cleavage site responsible for generating the 95 kDa stable fragment was less than
30 residues downstream of the caspase-3 cleavage site. To identify the site we utilized a
GST-fusion peptide containing residues 1583 to residue 1932 of rat InsP3R1, which
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includes the caspase-3 cleavage site (Supplemental Figure 2.1A). As a control, we used a
GST-fusion peptide containing an adjacent sequence within InsP3R1 (residues 1932 to
2257) that does not include the caspase-3 cleavage site. We digested both GST-fusion
peptides with exogenous calpain 1, separated reaction products using SDS-PAGE, and
transferred them to PVDF membranes for protein staining. Protein staining of digest
products identified a single proteolytic fragment derived from the 1582-1932aa peptide,
but not the 1932-2257aa peptide, confirming that the calpain-cleavage site is between
residues 1582 and 1932 (Supplemental Figure 2.1B). Addition of the calpain inhibitor
calpastatin blocked generation of the proteolytic fragment produced by calpain digest of
InsP3R1 peptide 1582-1932aa (Figure 2.1D). Eight rounds of Edman degradation and Nterminal sequencing of the proteolytic fragment from the calpain-digested GST-fusion
peptide returned 4 potential sequences, only one of which (1918ASAATRKA) was
downstream of the caspase-DEVD site (Figure 2.1E). Based on the location of this
sequence in InsP3R1, the predominant calpain cleavage product is expected to have a
molecular mass of 94.84 kDa. This fragment is 3.02 kDa smaller than the caspasecleaved fragment, which is consistent with Western blot comparisons of calpain and
caspase in vitro digests of microsomal InsP3R1 (Figure 2.1C). These data demonstrate
that calpain cleaves rat InsP3R1 between residues 1917 and 1918 to generate the 95 kDa
carboxyl-terminal fragment. The sequences surrounding the cleavage site are highly
conserved in InsP3R1 across species, although it is not present in type 2 or type 3
receptors.
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Calpain-cleaved InsP3R1 antibody
To facilitate investigations of calpain-cleaved InsP3R1, we generated an antibody
specific to the calpain-derived carboxyl-terminal fragment of the channel using a
neoepitope specific approach (Roberts-Lewis et al., 1994). The peptide ASAATRKAC,
corresponding to the new amino-terminus of InsP3R1 following calpain-cleavage, was
synthesized and covalently linked to a keyhole limpet hemocyanin to elicit an immune
response (Figure 2.2A; Covance ImmunoTechnologies). A New Zealand White rabbit
(2054) was immunized by subcutaneous injections of the peptide, and serum ELISA
demonstrated a 1:843,000 titer at the time of test-bleed 1.
We tested specificity of Ab2054 for the 95 kDa calpain-derived InsP3R1 fragment
by Western blot of rat cerebellar microsomes following in vitro digestion. Using a
carboxyl-terminal InsP3R1 antibody, we detected full-length, caspase-digested and
calpain-digested InsP3R1 (Figure 2.2B). Using Ab2054 on the same blot, we detected no
signal in undigested microsomes or microsomes digested with caspase-3, but a single
band at ~95 kDa was observed in microsomes digested with calpain 1, indicating the
antibody reacts exclusively with the stable 95 kDa calpain-cleaved form of InsP3R1
(Figure 2.2C). These data validate Ab2054 as specific antibody for calpain-cleaved
InsP3R1.
Expression of recombinant InsP3R1 constructs
To examine the consequences of calpain cleavage of InsP3R1 on channel function,
we generated a truncated cDNA of the protein (△1-1917) corresponding to the stable
carboxyl-terminal fragment derived from calpain cleavage (capn-InsP3R1). We used full41

length wild type (wt) rat InsP3R1 as a control (Figure 2.3A).
For all functional experiments, we studied wt- and capn-InsP3R1 expressed
transiently in N2a mouse neuroblastoma cells. We chose N2a cells as they are neural in
tissue origin and have high transfection efficiency. To examine the time course of
expression of recombinant rat InsP3R1 in N2a cells, we transiently transfected cells with
either wt-InsP3R1 or capn-InsP3R1 and harvested cells at 6, 16, 24, or 48 h later. Western
blotting of whole-cell lysates using the carboxyl-terminal InsP3R1 antibody demonstrated
expression of both wt- and capn-InsP3R1 by 6 h post-transfection. For capn-InsP3R1,
expression was maximal at 24 and decreased by 48 h post-transfection, whereas
expression of the wt channel continued to increase up to 48 h, suggesting toxicity or
cellular regulation of gene expression associated with capn-InsP3R1 (Figure 2.3B). In
lysates from wt-InsP3R1 cells, we occasionally observed lower molecular weight
fragments, which are possibly proteolytic degradation products. In lysates from cells
expressing capn-InsP3R1, we observed high molecular weight smears, which are likely
aggregates of capn-InsP3R1. Similar high molecular weight smears have been observed
when expressing the caspase-3 cleaved form of InsP3R1 (Nakayama et al., 2004). These
smears were eliminated by harvesting capn-InsP3R1 transfected cells in lysis buffer
containing either 5 M urea or 1% SDS (Supplemental Figure 2.2).
InsP3-independent gating of capn-InsP3R1
To determine whether capn-InsP3R1 still functioned as an ion channel, we
examined single channel activity in native ER membranes. We utilized patch clamp
electrophysiology of the outer membrane of isolated N2a cell nuclei to study the channel
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activities of recombinant InsP3R1 constructs (Foskett et al., 2007). To maximize the
likelihood of recording recombinant channels, we performed patch clamp experiments at
24 h post-transfection, when expression of capn-InsP3R1 was maximal. We monitored
channel activity with the pipette solution (cytoplasmic side) containing 2 µM Ca2+ and
0.5 mM ATP.

In untransfected cells, we observed endogenous InsP3R with single

channel conductance of 395 ± 12 pS with saturating 10 µM InsP3 in the pipette solution
(Supplemental Figure 2.3A-B). In nuclei from cells transfected with recombinant rat wtInsP3R1, we observed channel activities that had a smaller single channel conductance
(231 ± 10 pS; Supplemental Figure 2.3C).

Despite their smaller single channel

conductance, we identified these channels as InsP3R based on their dependence on InsP3
for activation (n=10; Figure 2.4A) and their sensitivity to competitive inhibition by
heparin (100 µg/ml in pipette solution; n=5; Figures 2.4A, 2.4C-D). With 10 µM InsP3 in
the pipette solution, the recombinant wt channels had an open probability (Po) of 0.69 ±
0.08 (n=8; Figures 2.4A, 2.4C-D). In cells transfected with capn-InsP3R1, we observed
channel activities with a single channel conductance (230 ± 10 pS) similar to the
recombinant wt-InsP3R1 (Supplemental Figure 2.3D). Strikingly, we observed these
channels even in the absence of InsP3 in the pipette solution. Exposed to pipette solution
containing no InsP3, 2 µM Ca2+ and 0.5 mM ATP, the spontaneously active capn-InsP3R1
channels had high Po in either the absence (Po=0.82 ± 0.04, n=9) or presence (Po=0.74 ±
0.09, n=5) of heparin (Figures 2.4B-D). These results indicate that a truncated InsP3R1
corresponding to the carboxyl-terminal calpain cleavage fragment forms a functional ion
channel with InsP3-independent gating.
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Ca2+ regulation of capn-InsP3R1 gating
Channel activity of InsP3R1 is both activated and inhibited by Ca2+, resulting in a
biphasic, bell-shaped Po dependence on [Ca2+]i (Foskett et al., 2007).

While InsP3

regulation of the truncated channel was absent, we asked whether any Ca2+ regulation of
capn-InsP3R1 remained. Accordingly, we next examined channel activity at low [Ca2+]
(70 nM), typical of resting cytoplasmic levels. With 10 µM InsP3 and 70 nM free Ca2+ in
the pipette solution, Po of wt-InsP3R1 was 0.016 ± 0.004 (n=8; Figures 2.5A, C),
significantly lower than the observed Po in 2 µM Ca2+ (Po~0.7; p<0.001). With no InsP3
and 70 nM free Ca2+ included in the pipette solution, Po of capn-InsP3R1 was 0.26 ± 0.06
(n=5; Figures 2.5B-C), also significantly lower than the observed Po in 2 µM Ca2+
(Po~0.8; p<0.001), but significantly higher than that of wt-InsP3R1 at low Ca2+
(p<0.001). These data suggest that capn-InsP3R1 may constitute an ER Ca2+ leak
permeability in resting cells.

To determine whether high [Ca2+] still inhibits capn-

InsP3R1, we examined channel activity at 25 µM Ca2+, which corresponds to pathologic
neuronal cytoplasmic levels immediately following ischemia (Erecinska and Silver, 1992;
Silver and Erecinska, 1992). With 10 µM InsP3 and 25 µM free Ca2+ in the pipette
solution, Po of wt-InsP3R1 was 0.22 ± 0.06 (n=8; Figures 2.5A, C). In the absence of
InsP3, with heparin (100 µg/ml) and 25 µM free Ca2+ in the pipette solution, Po of capnInsP3R1 was 0.39 ± 0.08 (n=8; Figures 2.5B-C). Po of wt- and capn-InsP3R1 channels in
25 µM Ca2+ were significantly lower than the corresponding Po of each channel in 2 µM
Ca2+ (p<0.001). Po of capn-InsP3R1 at 25 µM Ca2+ was not, however, significantly
different from Po of wt-InsP3R1 at that [Ca2+].

These data demonstrate that Ca2+

regulation of channel activity is preserved in capn-InsP3R1.
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Decreased intracellular Ca2+ stores in cells expressing capn-InsP3R1
To investigate the functional consequence of InsP3R1 proteolysis on cellular Ca2+
homeostasis, we first used single-cell Ca2+ imaging to examine [Ca2+]i and estimate total
Ca2+ content of intracellular stores. We identified individual transfected cells by EGFP
expression driven by the pIRES2-EGFP expression vector.

To avoid potential

complications from compensatory changes in gene expression, we performed Ca2+
imaging at an early time point (6 h) following transfection. [Ca2+]i was monitored with
Fura-2 in transiently transfected N2a cells expressing wt-InsP3R1, capn-InsP3R1 or a
control plasmid (EGFP). We utilized the Ca2+ ionophore ionomycin (2 µM) to liberate
Ca2+ from intracellular stores in the absence of extracellular Ca2+ and measured the
resulting increase in [Ca2+]i (Figure 2.6A). We used ionomycin instead of a
sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor because it
produces a much faster leak and consequent rise in [Ca2+]i, providing a better estimate of
the Ca2+ content of intracellular stores. Expression of capn-InsP3R1 did not effect resting
[Ca2+]i in N2a cells (Figure 2.6B). However, expression of capn-InsP3R1 significantly
decreased the ionomycin-induced peak [Ca2+]i (252 ± 15 nM) compared with control cells
(540 ± 30 nM) or cells over-expressing wt-InsP3R1 (520 ± 60 nM; p<0.001; Figure
2.6C). These data indicate that capn-InsP3R1 causes partial depletion of intracellular
Ca2+ stores consistent with the hypothesis that calpain-cleaved InsP3R1 is a Ca2+ leak
channel.
Decreased ER Ca2+ loading in cells expressing capn-InsP3R1
To directly examine ER Ca2+ leak caused by truncated InsP3R1, we monitored
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[Ca2+]ER in N2a cells using Mag-Fura-2 at 6 h post-transfection. We permeabilized the
plasma membranes of Mag-Fura-2 loaded EGFP expressing cells by a brief exposure to
digitonin under microscopic observation. After depleting ER stores by washing with
ATP-free CLM for 30 min, we initiated Ca2+ filling of ER stores by perfusing
permeabilized cells with saturating 1.5 mM MgATP to stimulate the SERCA pump.
After a steady-state [Ca2+]ER was reached, we observed the ER Ca2+ leak by inhibiting the
pump with CPA (10 µM) and removing ATP (Figure 2.7A). Expression of capn-InsP3R1
significantly decreased the steady-state loading level of the ER to 26.8 ± 1.1 µM
compared with 36.3 ± 0.9 µM in controls and 33.4 ± 1.0 µM in cells expressing wtInsP3R1 (p<0.001; Figure 2.7B).
To compare the kinetics of ER Ca2+ loading and passive leak in cells expressing
various InsP3R1 constructs, we determined the average rate of ER loading and release by
fitting each respective portion of single-cell responses with a single exponential equation.
Expression of capn-InsP3R1 reduced the rate of ER Ca2+ loading compared with cells
expressing wt-InsP3R1, although the rate was similar to that observed in EGFPexpressing cells (Figure 2.7C), suggesting that SERCA activity was sufficient to
overcome Ca2+ leak through the truncated channel. Expression of capn-InsP3R1 and, to a
lesser extent, wt-InsP3R1 significantly increased the ER Ca2+ leak rate compared with
control (p<0.001; Figure 2.7D). Taken together, these data demonstrate that calpaincleaved InsP3R1 alters ER Ca2+ homeostasis.
Calpain-mediated proteolysis of InsP3R1 following in vivo ischemia
To determine whether calpain proteolysis of InsP3R1 occurs in vivo in a clinically
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relevant injury model, we examined rat cerebellum following 7 min of asphyxial cardiac
arrest. We chose this model because cerebellar Purkinje neurons express high levels of
InsP3R1 and are selectively vulnerable to transient global ischemia caused by cardiac
arrest (Neumar, 2000).

We first performed Western blot analysis of rat cerebellar

microsomes from naïve animals or from animals resuscitated from cardiac arrest. Using
the carboxyl-terminal InsP3R1 antibody, which reacts with both unproteolyzed and
cleaved InsP3R1, we observed evidence of InsP3R1 proteolysis and the appearance of a
faint ~95 kDa fragment at both 1 and 24 h after return of spontaneous circulation (Figure
2.8A). Using Ab2054, which specifically recognizes the stable 95 kDa carboxyl-terminal
fragment generated by calpain proteolysis, we identified calpain-cleaved InsP3R1 in both
post-cardiac arrest samples (Figure 2.8B).
To determine which cell populations within the cerebellum contained calpaincleaved InsP3R1, we performed immunohistochemical analysis of rat cerebellum 24 and
48 h following cardiac arrest using naïve animals as a control (Figure 2.8C).
Immunolabeling with Ab38, which reacts with calpain-cleaved spectrin, demonstrated
robust calpain activity within sub-populations of Purkinje neurons at 24 h post-cardiac
arrest, which decayed but was still evident at 48 h post-cardiac arrest.

Using Ab2054,

we detected calpain-cleaved InsP3R1 in sub-populations of Purkinje neurons in a
distribution similar to that of calpain-cleaved spectrin (Figure 2.8C).

The intensity of

Ab2054 staining was comparable at 24 and 48 h after cardiac arrest, suggesting that the
calpain-derived InsP3R1 fragment is more stable than the spectrin fragment.
Finally, to evaluate the relationship between calpain cleavage of InsP3R1 and cell
death, we used Fluoro-Jade B to identify degenerating neurons in the cerebellum (Figure
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2.8C). At both time points examined following cardiac arrest, we observed selective
Fluoro-Jade labeling of sub-populations of Purkinje neurons. The intensity of FluoroJade staining was greater at 48 h compared with 24 h post-cardiac arrest, and was
accompanied by a shrunken somatic morphology consistent with neurodegeneration. The
morphological changes and increased Fluoro-Jade intensity in Purkinje cells at 48 h postinjury suggests that both enhanced calpain activity and cleavage of InsP3R1 precede
neurodegeneration. We did not observe any Ab38, Ab2054 or Fluoro-Jade labeling in
naïve tissue.
Together, these data demonstrate that calpain cleaves InsP3R1 in vivo in a
clinically relevant model of brain ischemia, and that calpain-mediated proteolysis of
InsP3R1 is an early molecular event in the injury cascade.
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DISCUSSION
The present study is the first functional investigation of calpain-cleaved InsP3R1.
Based on our results from single-channel electrophysiology and Ca2+ imaging
experiments, we conclude that capn-InsP3R1 forms a dysregulated channel with InsP3independent gating, which functions as a leak channel in the ER. Moreover, evidence of
calpain-mediated InsP3R1 proteolysis in the brain following cardiac arrest demonstrates
that InsP3R1 proteolysis is a clinically relevant cellular pathway that is active in a
neurodegenerative disease.
Calpain proteolyzes InsP3R1 at a unique cleavage site
Previous reports (Magnusson et al., 1993; Wojcikiewicz and Oberdorf, 1996;
Igwe and Filla, 1997) and data presented here (Figure 2.1) establish that InsP3R1 is a
proteolytic target of calpain, which cleaves the channel at multiple sites to form 200, 130,
and 95 kDa carboxyl-terminal fragments.

Calpains, unlike caspases, do not use

consensus sequences for target recognition and proteolysis. Our data show that calpain
cleaves InsP3R1 between residues 1917 and 1918 to generate the stable 95 kDa channel
fragment (Figure 2.1D-E). The InsP3R1 calpain cleavage site and surrounding residues
are highly conserved in mouse and human homologs, and are unique to the type 1
isoform of the channel. Our cleavage specific antibody (Ab2054; Figure 2.2) targeting
the new amino-terminus of InsP3R1 following calpain proteolysis provides a useful tool
for studying the truncated form of the channel in multiple species, including human (data
not shown).
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To begin characterizing the functional consequences of calpain proteolysis of
InsP3R1, we utilized a recombinant channel construct corresponding to the 95 kDa
carboxyl-terminal fragment of InsP3R1 produced by calpain cleavage (Figure 2.3). We
expected the recombinant truncated InsP3R1 to tetramerize in the ER, as previous studies
demonstrated that the transmembrane domains and carboxyl-terminal tail of the channel
are sufficient for ER localization and oligomerization (Sayers et al., 1997; Galvan et al.,
1999). We had attempted to study capn-InsP3R1 on a null-background using the InsP3Rdeficient DT40 cell line. The extremely low transfection efficiency of these cells requires
working in stable lines. However, we were unable to generate stable InsP3R-deficient
DT40 lines expressing capn-InsP3R1 despite our lab and others being able to generate
stable lines expressing the similarly sized caspase-3 cleaved form of the channel (Assefa
et al., 2004; Verbert et al., 2008).1 The apparent toxicity associated with expression of
capn-InsP3R1 in the DT40 cell system suggests that the truncated channel may cause cell
death or attenuate proliferation. Instead of using stable lines, we studied capn-InsP3R1 in
transiently transfected N2a cells at early time points following transfection to minimize
the impact of potentially confounding compensatory changes as seen in stable lines overexpressing wt-InsP3R1 (Fischer et al., 1994; Mackrill et al., 1996; Davis et al., 1999).
Furthermore, studying capn-InsP3R1 in transiently transfected cells expressed under the
CMV promoter strongly increases the probability that the recombinant truncated subunits
form homotetramers. Thus, heteroligomerization of truncated subunits with endogenous,
full-length InsP3R was unlikely in the studies presented here. However, understanding

1

C.M. Kopil, H. Vais, K.-H.Cheung, A.P. Siebert, D.-O.D. Mak, J.K. Foskett, and R. W.
Neumar, unpublished observation.
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the possible existence and implications of heteroligomerization of truncated and fulllength InsP3R requires additional studies.
Our approach to studying the functional consequence of calpain proteolysis of
InsP3R1 using capn-InsP3R1 does have limitations.

Foremost, it is unknown if the

amino-terminus of InsP3R1 completely dissociates from the channel domain following
proteolysis. Limited digestion of cerebellar microsomes with trypsin results in channel
fragments that remain associated via noncovalent or indirect interactions (Joseph et al.,
1995; Yoshikawa et al., 1999).

The trypsinized channel also remains functional,

demonstrated by InsP3-induced Ca2+ release from microsomes (Yoshikawa et al., 1999).
Thus, expression of capn-InsP3R1 may not accurately reflect the conformation that exists
following proteolysis in vivo. Caspase-3 proteolysis of InsP3R1 however, results in loss
of InsP3-mediated Ca2+ release from microsomes in a manner that corresponds to the
percentage of digestion (Hirota et al., 1999). The same is likely true for calpain-cleaved
InsP3R1.

By studying capn-InsP3R1, we are likely examining a model of an InsP3R1

channel in which all four subunits have been completely proteolyzed by calpain.
Understanding the behavior of InsP3R1 channels with both intact and calpain-cleaved
subunits warrants future investigation.
Calpain-cleaved InsP3R1 has InsP3-independent, Ca2+-dependent channel gating
To explore how calpain cleavage affects InsP3R1 channel function, we examined
the single channel properties of recombinant capn-InsP3R1 using nuclear patch clamp
electrophysiology.

Recordings from N2a nuclei expressing recombinant InsP3R1

revealed channels with smaller single channel conductances than that of endogenous
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InsP3R. This difference is potentially mediated by interactions with endogenous proteins,
which may modulate recombinant rat InsP3R1 activity differently than endogenous
mouse InsP3R. The low conductance of recombinant InsP3R1 was cell type specific, as
we did not observe such reduction in conductances when the channels were expressed in
HEK293 cells.2

Nevertheless, it provided a means to distinguish recombinant and

endogenous InsP3R channels in N2a cells. In examining capn-InsP3R1 specifically, we
observed activity of single channels in patches in the absence of InsP3, indicating that
calpain cleavage does not eliminate channel function but instead leads to constitutive
InsP3-independent gating (Figure 2.4B). Previous studies of the caspase-3 cleaved form
of InsP3R1 similarly suggested that the proteolyzed channel retained activity (Nakayama
et al., 2004; Verbert et al., 2008).
In addition to InsP3, Ca2+ is the most important ligand for InsP3R1 (Foskett et al.,
2007). Even in saturating concentrations of InsP3, [Ca2+]i greater than 100 nM is required
for the InsP3R1 channel to be appreciably activated (Foskett et al., 2007). Unlike the
InsP3-binding site in InsP3R1, which is known and missing in the carboxyl-terminal
fragment generated by calpain proteolysis, the location of functionally important Ca2+
binding sites within the primary sequence of InsP3 R1 are largely unknown (Foskett et al.,
2007).

Therefore, while we expected that capn-InsP3R1 activity would be InsP3-

independent if it formed a functional channel, we made no a priori assumptions about
Ca2+ regulation of capn-InsP3R1 activity. To experimentally determine if the Ca2+
requirement for channel activation was retained in capn-InsP3R1, we also studied

2

C.M. Kopil, H. Vais, K.-H.Cheung, A.P. Siebert, D.-O.D. Mak, J.K. Foskett, and R. W.
Neumar, unpublished observation.
52

recombinant channel gating at non-optimal [Ca2+] (70 nM and 25 µM). As expected, the
Po of wt-InsP3R1 was significantly decreased at 70 nM and 25 µM Ca2+ compared with
channel Po at optimal 2 µM Ca2+ (Figure 2.5). Notably, the constitutively active capnInsP3R1 channel demonstrated a similar behavior (Figure 2.5). This result suggests that
the carboxyl-terminal part of InsP3R1 beyond residue 1917 contains functionally relevant
Ca2+ binding sites involved in channel activation and inhibition. The Po of capn-InsP3R1
at 70 nM Ca2+ was, however, significantly greater than that of wt-InsP3R1 at this [Ca2+].
This difference may reflect loss of the high affinity, InsP3-regulated Ca2+ binding site in
the truncated channel (Foskett et al., 2007). However, because of the complexity of Ca2+
regulation of InsP3R channel activity, involving multiple functional Ca2+ binding sites
(Foskett et al., 2010), future studies are required to determine what elements of Ca2+
regulation are modified in the truncated channel. These investigations may provide
critical clues needed to identify additional Ca2+ binding sites within the primary InsP3R
sequence.
Expression of capn-InsP3R1 decreases Ca2+ content of intracellular Ca2+ stores
How does InsP3-independent activity of capn-InsP3R1 affect cellular Ca2+
regulation? Using changes in [Ca2+]i to indirectly measure the Ca2+ content of
intracellular stores, we observed that expression of capn-InsP3R1 significantly reduced
ionomycin releasable Ca2+ compared with wt-InsP3R1 and EGFP controls, although it did
not completely deplete intracellular stores (Figure 2.6A and C). The kinetics of the
ionomycin response in capn-InsP3R1 expressing cells was also slower than in EGFP wtInsP3R1 controls, which suggests a smaller Ca2+ driving force, consistent with a smaller
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intracellular Ca2+ store. On the other hand, expression of capn-InsP3R1 was not
associated with an increased basal [Ca2+]i, suggesting that Ca2+ transport mechanisms
were able to compensate for enhanced ER Ca+ leak through the cleaved channel, at least
at the early times after transfection studied (Figure 2.6B).

In ER Ca2+ imaging

experiments, expression of capn-InsP3R1 significantly reduced the steady-state Ca2+
loading capacity of the ER compared with wt-InsP3R1 and EGFP controls (Figure 2.7A
and B). The steady-state [Ca2+]ER represents the equilibrium between the passive Ca+
leak and Ca2+ uptake by SERCA. Under steady-state filling conditions, the enhanced
Ca2+ leak induced by expression of capn-InsP3R1 exceeds the SERCA mediated Ca2+
uptake rate, resulting in lower [Ca2+]ER. The small effect of capn-InsP3R1 expression on
the ER filling rate may reflect the negligible driving force for Ca2+ leak under these
conditions (Figure 2.7C). Of note, the ER leak rate in capn-InsP3R1 was considerably
higher than that observed in control or wt-InsP3R1 expressing cells. (Figure 2.7D).
Taken together, our results suggest that capn-InsP3R1 acts as a Ca2+ leak channel that
perturbs normal ER Ca2+ homeostasis.
The results from nuclear patch clamp electrophysiology and Ca2+ imaging
experiments together elucidate the physiologic relevance of calpain-mediated InsP3R1
proteolysis.

Evidence that InsP3-independent gating of capn-InsP3R1 remains Ca2+

dependent may explain why expression of capn-InsP3R1 induces only a moderate, albeit
significant decrease in intracellular and ER Ca2+ stores, at least at the early time point
examined following transfection (6 h). The electrophysiology data suggest that resting
[Ca2+]i is insufficient to fully activate the truncated channel, thus reducing the Ca2+ leak.
It is interesting to speculate that this result may also account for conflicting findings
54

regarding the effects of caspase-3 cleavage of InsP3R1 on Ca2+ homeostasis. Previous
studies have reported that expression of caspase-cleaved InsP3R1, which is only 26
residues longer than the calpain-cleaved form, either depletes (Nakayama et al., 2004) or
does not deplete (Verbert et al., 2008) Ca2+ stores in the resting state. While it was
agreed that caspase-3-cleaved InsP3R1 represents a leak channel, the size and impact of
that leak remains disputed. It is possible that different [Ca2+]i in the two studies resulted
in channels with different Po, which would likely lead to distinct effects on cellular Ca2+
homeostasis. Electrophysiological recordings of caspase-cleaved InsP3R1, similar to
those performed here for capn-InsP3R1, may clarify the functional consequences of
caspase-mediated channel proteolysis.
InsP3R1 is cleaved by calpain following ischemic brain injury
Under pathologic conditions, particularly those associated with elevated [Ca2+]i
and impaired ATP-dependent Ca2+ removal mechanisms, as in ischemia, calpain cleavage
of InsP3R1 may be an important mechanistic component of cell death. Brain ischemia
and reperfusion dramatically disrupt neuronal Ca2+ homeostasis, and there is compelling
evidence for a causal role of both Ca2+ overload and consequent pathologic calpain
activation in ischemic neurodegeneration (Neumar, 2000; Bevers and Neumar, 2008). As
both a Ca2+ regulatory protein and calpain substrate, InsP3R1 is at a critical intersection
between protease activation and disruption of cellular Ca2+ homeostasis during the
molecular injury cascade. Here, we demonstrate that InsP3R1 proteolysis occurs in vivo
in an animal model of ischemic brain injury (Figure 2.8). In this cardiac arrest model,
calpain cleavage of InsP3R1 occurred in cerebellar Purkinje neurons, which are
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selectively vulnerable to post-ischemic neurodegeneration (Neumar, 2000). Moreover,
identification of calpain-cleaved InsP3R1 in cerebellar microsomes as early as 1 h after
cardiac arrest and reperfusion demonstrates that channel proteolysis is an early event in
the cell death cascade rather than merely reflecting broad cellular degradation. The
persistence and stability of calpain-cleaved InsP3R1 at the latest time point examined
after cardiac arrest (48 h) also suggests that the leaky, proteolyzed channel may act as a
feed-forward mechanism for Ca2+ overload and increased calpain activation that
eventually lead to neuronal death. In addition to InsP3R1, a number of Ca2+ regulatory
proteins are also calpain substrates, including the NMDA receptor, plasma membrane
Ca2+-ATPase, Na+/Ca2+ exchanger, L-type Ca2+ channel, SERCA and ryanodine receptor
(Bevers and Neumar, 2008). Thus, calpain cleavage of InsP3R1 may be an important
component of a broader pathway of calpain-mediated disruption of neuronal Ca2+
homeostasis in neurodegenerative diseases associated with Ca2+ dysregulation.
Conclusions
In summary, our results indicate that calpain proteolysis of InsP3R1 creates an ER
Ca2+ release channel that is InsP3-independent and constitutively active. Expression of
the truncated channel reduces the content of intracellular Ca2+ stores, which may have
detrimental effects on Ca2+ signaling and buffering under pathologic conditions.
Evidence of calpain cleavage of InsP3R1 in neurons following cardiac arrest provides a
potential mechanism to account for decreased InsP3 binding (Nagasawa and Kogure,
1991; Dahl et al., 2000), depletion of ER Ca2+ stores (Kohno et al., 1997) and disruption
of Ca2+ homeostasis reported in previous studies of in vivo brain ischemia. Together,
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these results provide important insights into a molecular pathway that may act as a feedforward mechanism to enhance cell death.

Futhermore, the results presented here

identify a novel target for therapeutic intervention following brain ischemia or in other
neurodegenerative disorders associated with Ca2+ dysregulation and protease activation.
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FIGURES AND LEGENDS
Figure 2.1

Figure 2.1 Calpain cleavage site in InsP3R1
(A) Domain structure of InsP3R1 protein (top), and GST-InsP3R1 fusion peptide containing residues 1583
to 1932 (bottom). Residues numbered according to rat type 1 SI+, SII+, SIII- sequence (protein accession
NP_001007236.1). (B) Western blot of rat cerebellar microsomes following in vitro digestion with calpain1 using antibody against the carboxyl-terminal 20 amino acids of rat InsP3R1 (1:5,000). Digestion with
calpain-1 results in cleavage of InsP3 R1 into 200, 130 and 95 kDa carboxyl-terminal fragments. With
longer digestion, the 95 kDa fragment becomes predominant. Proteolysis does not occur in the absence of
Ca2+ and is blocked by the addition of the calpain inhibitor calpastatin (CAST), demonstrating the calpain
dependence. (C) Western blot of microsomes following in vitro digest with caspase-3 (4 h) and calpain-1
(1 h) using carboxyl-terminal InsP3R1 antibody, demonstrating difference in size of the resulting stable
carboxyl-terminal InsP3R1 fragments. (D) Amido black protein stain of PVDF membrane demonstrating
calpain-mediated degradation of the GST-InsP3 R1 fusion peptide. Arrow indicates unique calpaindegradation product, which was not present in samples without exogenous calpain or samples treated with
CAST. The ~12 kDa band (arrow) was submitted for N-terminal sequencing. (E) Amino acid sequence of
InsP3R1 at caspase-3 and calpain-cleavage sites. DEVD consensus sequence for caspase-3 proteolysis
highlighted in red. The new N-terminus of InsP 3R1 generated by calpain proteolysis and the sequence
identified by Edman N-terminal sequencing is underlined and highlighted in red.
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Figure 2.2

Figure 2.2 Antibody targeted against calpain-cleaved InsP3R1
(A) Calpain cleavage site of rat InsP3 R1 and corresponding synthetic peptide used to generate polyclonal
antibody Ab2054. (B) Western blot of rat cerebellar microsomes following in vitro digestion with caspase-3
or calpain 1 using carboxyl-terminal InsP3R1 antibody that reacts with unproteolyzed, caspase-cleaved and
calpain-cleaved InsP3R1. (C) Western blot in B, stripped and reprobed using Ab2054 (1:10,000). Ab2054
reacts specifically with the 95 kDa carboxyl-terminal fragment of calpain-cleaved InsP3R1.
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Figure 2.3

Figure 2.3 Schematic representation and expression of recombinant capn-InsP3R1
(A) Domain structure of the full-length (wt) and calpain-cleaved InsP3R1 recombinant proteins. (B)
Western blot analysis of whole cell lysates from untransfected N2a cells or N2a cells expressing wt- or
capn-InsP3R1 at 6, 16, 24 and 48 h post-transfection. Carboxyl-terminal InsP3R1 antibody was used to
detect endogenous and recombinant InsP3R1. Antibody against actin (1:3,000) used as loading control.
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Figure 2.4

Figure 2.4 Capn-InsP3R1 channel activity in the absence of InsP3
(A) Representative current traces recorded in outer membrane of nuclei isolated from N2a cells transfected
with wt-InsP3 R1 in the absence (top panel) or presence (middle/bottom panels) of saturating InsP3 in the
pipette solution. Pipette solution contained 2 µM Ca2+. Arrow indicates closed channel current level.
Channel activity of wt-InsP3R1 required InsP3 and was inhibited by heparin. (B) Representative current
recordings in isolated nuclei from N2a cells expressing capn-InsP3R1 in absence of InsP3. Heparin did not
inhibit channel activity of capn-InsP3R1, confirming that InsP3-independent gating was not caused by local
InsP3 in the patch pipette. (C) Summary of effects of InsP3 and heparin on Po of recombinant InsP3R1. (D)
Summary of Po from endogenous InsP3R (Endo InsP3R) and recombinant wt- and capn-InsP3R1. There is
no statistically significant difference between mean Po values of recombinant wt- and capn-InsP3R1 by oneway ANOVA.
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Figure 2.5

Figure 2.5 Ca2+ regulation of capn-InsP3R1
(A) Representative current traces recorded in outer membrane of nuclei isolated from N2a cells transfected
with wt-InsP3R1 with 10 µM InsP3 and 70 nM (top), 2 µM (middle), or 25 µM (bottom) Ca2+ included in
the pipette solution. (B) Representative current traces recorded in outer membrane of nuclei isolated from
N2a cells transfected with capn-InsP3R1 in the absence of InsP3 with 70 nM (top), 2 µM (middle), or 25
µM (bottom) Ca2+. (C) Summary of effects of [Ca2+] on Po of wt- and capn-InsP3R1 (Po data at 2 µM Ca2+
are the same as shown in Figure 2.4). Po of both wt- and capn-InsP3R1 at 70 nM and 25 µM Ca2+ were
decreased compared to the Po of either channel at 2 µM Ca2+ (unpaired t-tests, p<0.001). At 70 nM Ca2+, Po
of capn-InsP3R1 was higher than that of wt-InsP3R1 at 70 nM Ca2+ (unpaired t-test with unequal variance;
*, p<0.001).
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Figure 2.6

Figure 2.6 Expression of capn-InsP3R1 decreases Ca2+ content of intracellular stores
(A) Averaged single-cell [Ca2+]i responses to 2 µM ionomycin in Fura-2 loaded N2a cells transfected with
empty vector (green), wt-InsP3R1 (blue) or capn-InsP3R1 (red). (B) Summary of resting [Ca2+]i. (C)
Summary of peak [Ca2+]i responses elicited by 2 µM ionomycin, demonstrating a decrease in releasable
Ca2+ in capn-InsP3R1 expressing cells (unpaired t-tests with unequal variance; *, p<0.001).
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Figure 2.7

Figure 2.7 Capn-InsP3R1 decreases ER Ca2+ loading
(A) Averaged single-cell responses demonstrating ER Ca2+ loading and release in response to 1.5 mM
MgATP and 10 µM CPA/ 0 ATP, respectively. Averaged traces are from permeabilized Mag-Fura-2
loaded N2a cells transfected with empty vector (green), wt-InsP3R1 (blue) or capn-InsP3R1 (red). (B)
Summary of steady state [Ca2+]ER, showing decreased ER loading in cells expressing capn-InsP3R1 (oneway ANOVA; *, p<0.001). (C) Summary of averaged single-cell ER loading rates in response to MgATP
stimulation of SERCA in transfected cells (unpaired t-tests; *, p<0.05, **, p<0.01). (D) Summary of
averaged single-cell ER leak rates in response to CPA inhibition of SERCA in transfected cells.
Expression of capn-InsP3R1 and to a lesser extent wt- InsP3R1 increase leak rate compared to control
(unpaired t-tests with unequal variance; *, p<0.001).
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Figure 2.8

Figure 2.8 Calpain-cleavage of InsP3R1 in vivo following cardiac arrest
Western blot of rat cerebellar microsomes 1 and 24 h after resuscitation from cardiac arrest. (A) A
carboxyl-terminal InsP3R1 antibody used to detect full-length and cleaved InsP3R1 shows the appearance
of a faint band at 95 kDa with cardiac arrest. An antibody against calreticulin (CRT; 1:1,000) was used as a
loading control. (B) Western blot in A stripped and reprobed with Ab2054, demonstrating calpain-cleaved
InsP3R1 in post-cardiac arrest samples. (C) Immunofluorescence staining of naïve rat cerebellum and rat
cerebellum 24 and 48 h after resuscitation from cardiac arrest. Arrows indicate Purkinje cell layer. Ab38
(1:10,000; top panel) was used as a marker of calpain-activity with a Hoechst counterstain. Following
heat-induced epitope retrieval, Ab2054 (1:10,000; middle panel) labels calpain-cleaved InsP3 R1 with a
Hoechst counterstain. Fluoro-Jade B was used to label degenerating neurons (bottom panel). Here, we
detect calpain-activity, calpain-cleaved InsP3R1 and neurodegeneration in Purkinje cells from post-cardiac
arrest brains.
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SUPPLEMENTAL DATA

Supplemental Figure 2.1

Supplemental Figure 2.1 Site-specific calpain proteolysis of InsP3R1
(A) Schematic of the linear InsP3R1 protein with regions corresponding to two different GST-InsP3R1
fusion peptides indicated as A and B (top). GST-InsP3R1 fusion peptides containing residues 1583 to 1932
(peptide A) or residues 1932 to 2257 (peptide B) are also depicted (bottom). (B) Amido black protein stain
of PVDF membrane demonstrating calpain mediated degradation of GST-InsP3R1 fusion peptide A
following 8 h incubation with exogenous calpain 1. Arrow indicates the unique calpain-degradation
product, which was not present in either undigested peptide or calpain-digested fusion peptide B.
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Supplemental Figure 2.2

Supplemental Figure 2.2 High molecular weight smears of capn-InsP3R1 can be solubilized and
denatured
Western blot analysis of whole cell lysates from N2a cells expressing capn-InsP3R1 at 24 h posttransfection. Cells were harvested in standard homogenization buffer (lane 1) or buffer supplemented with
5 M urea (lane 2) or 1% SDS (lane 3). Lysis buffer containing urea or SDS resolved the high molecular
weight smear associated with expression of capn-InsP3R1. Carboxyl-terminal InsP3R1 antibody was used
to detect endogenous and recombinant InsP3 R1. Antibody against actin was used as loading control.
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Supplemental Figure 2.3

Supplemental Figure 2.3 Recombinant rat InsP3R1 channels have smaller conductances than
endogenous InsP3R in N2a cells
(A) Representative current traces recorded in outer membrane of nuclei isolated from untransfected N2a
cells with 2 µM Ca2+ and 10 µM InsP3 included in the pipette solution. Channel activity of endogenous
InsP3R required InsP3. (B) I-V relation from voltage-ramp protocol for endogenous InsP3R in untransfected
N2a cells. (C) I-V relation for recombinant wt-InsP3R1 with 2 µM Ca2+ in presence of InsP3. (D) I-V
relation for capn-InsP3R1 from voltage-ramp protocol with 2 µM Ca2+ in absence of InsP3. Capn-InsP3R1
displays linear I-V relation, characteristic of InsP3 R1.
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SUMMARY
Disruption of neuronal Ca2+ homeostasis plays a well-established role in cell death in a
number of neurodegenerative disorders. Recent evidence suggests that proteolysis of the
type 1 inositol 1,4,5-trisphosphate receptor (InsP3R1), a Ca2+ release channel on the
endoplasmic reticulum (ER), generates a dysregulated channel, which may contribute to
aberrant Ca2+ signaling and neurodegeneration in disease states. However, the specific
effects of InsP3R1 proteolysis on neuronal Ca2+ homeostasis are unknown, as are the
functional contributions of this pathway to neuronal death. This study evaluates the
consequences of calpain-mediated InsP3R1 proteolysis on neuronal Ca2+ signaling and
survival using adeno-associated viruses to express a recombinant cleaved form of the
channel (capn-InsP3R1) both in vitro and in vivo. Here, we demonstrate that expression
of capn-InsP3R1 in rat primary cortical neurons reduced cellular viability. This effect
was associated with increased resting cytoplasmic Ca2+ concentration ([Ca2+]i), increased
[Ca2+]i response to glutamate, and enhanced sensitivity to excitotoxic stimuli. In vivo,
expression of capn-InsP3R1 in rat brain triggered selective degeneration of CA2
pyramidal neurons in the hippocampus. Together, our results demonstrate that InsP3R1
proteolysis disrupts neuronal Ca2+ homeostasis, and potentially acts as a feed-forward
pathway to initiate or execute neuronal death.
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INTRODUCTION
Spatial and temporal regulation of cytoplasmic free Ca2+ concentration ([Ca2+]i)
plays a vital role in neuronal signaling, and dysregulation of [Ca2+]i can trigger neuronal
cell death (Berridge et al., 2000; Berridge et al., 2003; Orrenius et al., 2003; Mattson,
2007). Under physiological conditions, changes in neuronal [Ca2+]i are tightly controlled
by transmembrane Ca2+ pumps, Ca2+-binding proteins, and intracellular organelles. The
endoplasmic reticulum (ER), the primary Ca2+ storage organelle in neurons, is capable of
both Ca2+ sequestration and release. Proper ER Ca2+ regulatory function is essential to
neuronal [Ca2+]i buffering, signaling, and survival (Mattson et al., 2000; Bardo et al.,
2006; Stutzmann and Mattson, 2011).
A ubiquitous mechanism for Ca2+ signaling in neurons is Ca2+ release from the
ER lumen through the inositol 1,4,5-trisphosphate receptor (InsP3R) (Foskett et al.,
2007). Of the 3 identified InsP3R genes, type 1 InsP3R (InsP3R1) is the most abundant
isoform expressed in the brain (Furuichi et al., 1993; Sharp et al., 1993). Physiological
InsP3R1-mediated Ca2+ signaling in neurons is important for gene expression, synaptic
plasticity, membrane excitability, and learning and memory (Furuichi and Mikoshiba,
1995; Bardo et al., 2006; Foskett et al., 2007). InsP3R1 dysfunction has been implicated
in a number of neurodegenerative disease states as a mechanism for impaired ER Ca2+
buffering, disruption of neuronal Ca2+ homeostasis, and neuronal death (Verkhratsky and
Toescu, 2003; Foskett, 2010). In most of these cases, InsP3R1 dysfunction has been
associated with allosteric modulation of the channel (Foskett et al., 2007). However,
increasing evidence suggests that proteolytic modification of InsP3R1 can also
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dramatically disrupt channel physiology (Assefa et al., 2004; Nakayama et al., 2004;
Verbert et al., 2008; Kopil et al., 2011), and may potentially contribute to
neurodegeneration.
InsP3R1 is a target for caspase-3 and calpain-mediated proteolysis, which
generate similarly sized ~95 kDa carboxyl-terminal fragments (Magnusson et al., 1993;
Wojcikiewicz and Oberdorf, 1996; Hirota et al., 1999; Haug et al., 2000; Kopil et al.,
2011). Both caspase and calpain-mediated proteolysis of InsP3R1 remove the aminoterminal ligand-binding domain and a large portion of the coupling domain, leaving the
pore-forming transmembrane domains intact.

Studies examining the functional

properties of the caspase-derived carboxyl-terminal InsP3R1 fragment demonstrated
increased ER Ca2+ leak, and corresponding decreased ER [Ca2+] ([Ca2+]ER) and buffering
capacity in cell lines expressing the recombinant channel (Assefa et al., 2004; Nakayama
et al., 2004; Verbert et al., 2008). These effects were mediated by InsP3-independent
Ca2+ release through caspase-cleaved InsP3R1, and expression of the truncated channel
increased cellular sensitivity to apoptotic stimuli (Assefa et al., 2004). Our laboratory
recently identified the calpain-cleavage site for InsP3R1 and determined that the calpainderived carboxyl-terminal channel fragment displayed InsP3-independent gating and
constitutive channel activity (Kopil et al., 2011). When expressed in cell lines, calpaincleaved InsP3R1 decreased [Ca2+]ER via increased ER Ca2+ leak (Kopil et al., 2011).
Although no study to date has investigated the effects of caspase- or calpain-cleaved
InsP3R1 on neuronal Ca2+ homeostasis, these observations suggest that proteolysis of
InsP3R1 may profoundly transform spatial and temporal regulation of neuronal [Ca2+]i
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and potentially signal cell death.

Consistent with this hypothesis, we previously

identified calpain-cleaved InsP3R1 in selectively vulnerable cerebellar Purkinje cells at
both early and late times following ischemic brain injury (Kopil et al., 2011).
To define the role of InsP3R1 proteolysis in disruption of neuronal Ca2+
homeostasis and neurodegeneration, we examined responses of primary neurons and
neurons in vivo to expression of calpain-cleaved InsP3R1. Expression of the cleaved
channel reduces viability of primary cortical neurons, and increases their sensitivity to
excitotoxic injury. Using single-cell Ca2+ imaging, we have determined that calpaincleaved InsP3R1 increases resting neuronal [Ca2+]i and leads to greater rises in [Ca2+]i in
response to physiological stimuli. Interestingly, we found that expression of calpaincleaved InsP3R1 also causes degeneration of a select subpopulation of hippocampal
neurons in vivo. Together, these data suggest a specific role for proteolyzed InsP3R1mediated Ca2+ signaling in the molecular injury cascade in neurons, which has important
therapeutic implications for neurodegenerative disorders associated with Ca2+
dysregulation.
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RESULTS
Expression of recombinant InsP3R1 constructs in primary cortical neurons
Previously, we showed that expression of a recombinant form of rat InsP3R1
corresponding to the stable carboxyl-terminal fragment generated by calpain proteolysis
(capn-InsP3R1; ∆1-1917; Figure 3.1A) altered [Ca2+]i homeostasis in immortalized cell
lines. In the current study we examined the functional consequences of capn-InsP3R1
expression in neurons, which are a more metabolically demanding and electrically active
cell type.

To achieve high transduction efficiency of primary cortical cultures, we

utilized adeno-associated virus (AAV) 2/1 mediated gene delivery of capn-InsP3R1,
which transduces over 90% of cells in primary mixed cortical cultures (Royo et al., 2008;
Bevers et al., 2009).

As a control for InsP3-independent Ca2+ release through the

truncated channel, we generated AAV 2/1 vector expressing capn-InsP3R1 with a
D2550A point mutation in the putative pore-forming region of the channel (capn-InsP3R1
D2550A; Figure 3.1A). This point mutation eliminates Ca2+ permeability of wild type
(wt) InsP3R1 (Boehning and Joseph, 2000; Boehning et al., 2001; Cardenas et al., 2010).
Because of the genome size of AAV, viral packaging capacity of transgenes is limited
(Dong et al., 1996), and we were unable to generate control AAV vectors expressing the
8.5 kb full-length InsP3R1 with or without the D2550A mutation. We used AAV 2/1
expressing lacZ to control for effects of viral transduction.
To examine expression of InsP3R1 constructs in neurons, we stably transduced
cortical cultures with AAV 2/1 expressing capn-InsP3R1, capn-InsP3R1 D2550A, or lacZ
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at 7 d in vitro (DIV) and harvested cells 1 week later (14 DIV). Western blotting of
whole-cell lysates using a carboxyl-terminal InsP3R1 antibody demonstrated expression
of endogenous 260 kDa wt-InsP3R1 in all samples (Figure 3.1B). In lysates from cultures
transduced with capn-InsP3R1 and capn-InsP3R1 D2550A, we also detected the 95 kDa
form of the channels confirming expression of our recombinant InsP3R1 constructs.
Expression of capn-InsP3R1 reduces viability of primary cortical neurons
To determine the effects of capn-InsP3R1 on viability of primary cortical neurons,
we transduced 7 DIV cultures with capn-InsP3R1, capn-InsP3R1 D2550A, or lacZ control
vectors.

One week post-transduction (14 DIV), we immunostained the cultures for

microtubule associated protein 2 (MAP2; Figure 3.2A, left) and quantified the number of
surviving neurons (Figure 3.2B). Expression of capn-InsP3R1 resulted in significant
decrease in the percentage of viable neurons compared with expression of capn-InsP3R1
D2550A or lacZ (capn-InsP3R1=65.3 ± 5.5%, capn-InsP3R1 D2550A=112.7 ± 5.8%,
lacZ=100.0 ± 3.8%; p<0.001). To confirm the capn-InsP3R1 toxicity phenotype, we
incubated transduced cultures with calcein-AM and propidium iodide (PI) to identify
living and dead cells respectively (Figure 3.2A, right). A significant decrease in the
percentage of surviving cells was again observed in cultures transduced with capnInsP3R1

compared

with

controls

(capn-InsP3R1=76.7

±

4.5%,

capn-InsP3R1

D2550A=112.5 ± 6.5%, lacZ=100.0 ± 4.0%; p<0.001; Figure 3.2C). Interestingly, the
percentage of viable cells in capn-InsP3R1-transduced cultures determined by calceinAM and PI staining was significantly higher than the percent of viable cells in the same
cultures quantified by counts of MAP2 labeled cells (p<0.05). This likely reflects the
76

mixed constituents of the cortical cultures, which contain ~10% glia 3 that are identified
using calcein-AM but not MAP2, suggesting that glial viability is not altered by capnInsP3R1. Together, these results suggest that expression of capn-InsP3R1 specifically
reduces neuronal viability.
We hypothesized that expression of capn-InsP3R1 reduced neuronal viability by
disrupting intracellular Ca2+ homeostasis. The recombinant cleaved channel, which has
InsP3-independent gating and increases ER Ca2+ leak (Kopil et al., 2011), could
potentially trigger neurodegeneration through either ER Ca2+ depletion and induction of
ER stress, or by increased [Ca2+]i and feed-forward activation of proteases. To examine
the mechanism responsible for capn-InsP3R1 reductions in neuronal viability, we
performed Western blotting of whole-cell lysates from transduced cultures. Using an
antibody against the stress-inducible ER chaperone protein BiP (Supplemental Figure
3.1A), we did not detect differences in activation of the ER stress pathway in capnInsP3R1-transduced cultures compared with controls (Supplemental Figure 3.1B). Nor
did we detect differences in calpain or caspase-3 protease activation using an antibody
against a shared substrate, α-spectrin (Supplemental Figures 3.1C and D). Absence of
Western blot evidence of increased ER stress or protease activation with expression of
capn-InsP3R1 does not conclusively imply that neither pathologic cascade plays a causal
role in capn-InsP3R1 induced neuronal death. However, if either pathway is responsible
for executing cell death in capn-InsP3R1-transduced cultures, Western blotting of
neuronal lysates is not sensitive enough to detect it at the times examined here.
3

C.M. Kopil, A.P. Siebert, J.K. Foskett and R.W. Neumar, unpublished observation.
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Capn-InsP3R1 does not deplete intracellular Ca2+ stores
Previous data from our laboratory indicated that capn-InsP3R1 functions as a Ca2+
leak channel in the ER (Kopil et al., 2011). To examine whether this leak was sufficient
to deplete intracellular Ca2+ stores in neurons, we utilized single-cell Ca2+ imaging to
measure InsP3-induced changes in [Ca2+]i. We monitored somatic [Ca2+]i using Fura-2 in
primary cortical cultures transduced with capn-InsP3R1, capn-InsP3R1 D2550A or lacZ
(Figure 3.3A).

To stimulate Ca2+ release from InsP3-sensitive stores, we applied

saturating concentrations of the Group I metabotropic glutamate receptor agonist (S)-3,5dihydroxyphenylglycine (DHPG; 10 µM).

Expression of capn-InsP3R1 significantly

increased resting [Ca2+]i in neurons (90 ± 3.3 nM) compared with capn-InsP3R1 D2550A
(70 ± 1.8 nM) and lacZ controls (70 ± 1.6 nM; p<0.001; Figure 3.3B), supporting
previous evidence that capn-InsP3R1 leaks Ca2+ from the ER. Application of DHPG
elicited responses, defined as >10% increase from baseline, in a majority of neurons from
all transduced cultures (Figure 3.3C). Despite the apparent basal Ca2+ leak through the
cleaved channel, expression of capn-InsP3R1 did not affect the DHPG-induced peak
[Ca2+]i in neurons (Figure 3.3D) or the maximum change in [Ca2+]i from baseline to peak
(Figure 3.3E). These data demonstrate that expression of the cleaved channel, while
sufficient to increase resting [Ca2+]i, does not deplete [Ca2+]ER.
Decreased ER Ca2+ buffering in neurons expressing capn-InsP3R1
To examine the effect of calpain-cleaved InsP3R1 on neuronal Ca2+ homeostasis
more broadly, we measured changes in [Ca2+]i in response to acute glutamate (10 µM)
application (Figure 3.4A), which activates both ionotropic and metabotropic glutamate
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receptors (Michaelis, 1998). Consistent with results from Ca2+ imaging experiments
above, resting [Ca2+]i was significantly increased in neurons expressing capn-InsP3R1
compared with capn-InsP3R1 D2550A and lacZ expressing cells (p<0.001; Figure 3.4B).
Additionally, expression of capn-InsP3R1 significantly increased the glutamate-induced
peak [Ca2+]i (1,520 ± 43 nM) compared with capn-InsP3R1 D2550A (1,030 ± 36 nM) and
lacZ controls (940 ± 25 nM; p<0.001; Figure 3.4C). Stimulation of an alternate pathway
for Ca2+ influx also resulted in a significantly increased peak [Ca2+]i in cultures
transduced with capn-InsP3R1 (50 mM KCl; Supplemental Figure 3.2).

This result

suggests that the increased glutamate-induced [Ca2+]i in capn-InsP3R1-transduced
neurons is not dependent on increased glutamate receptor expression.

Instead, the

increased [Ca2+]i rise is likely due to an impaired ability to buffer Ca2+ influx from the
extracellular space. Together, these data indicate that capn-InsP3R1 disrupts normal
intracellular Ca2+ homeostasis.
Capn-InsP3R1 increases sensitivity to glutamate-induced neurotoxicity
To determine whether the observed capn-InsP3R1-induced impairment of ER Ca2+
buffering increased neuronal susceptibility to excitotoxic injury, we exposed transduced
14 DIV primary cortical cultures to 1 µM glutamate or HEPES buffered saline (HBS)
vehicle. We selected this dose from initial studies performed in untransduced cultures,
where treatment with 1 µM glutamate resulted in negligible injury (Supplemental Figure
3.3). After incubation in glutamate for 24 h, the cultures were immunostained for MAP2
to quantify the number of surviving neurons (Figure 3.5A). To account for baseline
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differences in viability between capn-InsP3R1- and control-transduced cultures, the
percentage of MAP2-positive neurons in glutamate-injured cultures was normalized to
vehicle-treated cultures transduced with the same vector. Exposure to 1 µM glutamate
resulted in significant loss of neurons in all cultures compared with vehicle treated
controls (p<0.05). Interestingly, cultures transduced with capn-InsP3R1 were particularly
susceptible (survival: capn-InsP3R1=36.9 ± 10.6%, capn-InsP3R1 D2550A=77.2 ±
10.1%, lacZ=79.5 ± 9.2%; p<0.001). This result indicates that capn-InsP3R1 increases
neuronal susceptibility to excitotoxic injury.
To further examine the enhanced vulnerability to glutamate-mediated injury in
capn-InsP3R1-transduced cultures, we treated primary cortical neurons with a wide range
of glutamate doses (0.01 to 50 µM). As we did not observe differences between neuronal
survival in lacZ- and capn-InsP3R1 D2550A-transduced cultures at baseline or following
glutamate injury, we chose a single control (lacZ) for these experiments. Transduced
primary cortical neurons were incubated with glutamate or HBS vehicle and the number
of surviving neurons was quantified 24 h later by MAP2 staining (Figure 3.5B).
Glutamate concentrations ≥ 0.3 µM induced significant loss of neurons in cultures
transduced with capn-InsP3R1 (p<0.01), whereas lacZ-transduced cultures were only
sensitive at concentrations ≥ 1 µM. To facilitate comparison across doses, we fit data
using a Hill equation to produce normalized dose-response curve.

Capn-InsP3R1

expression resulted in a leftward shift of the glutamate dose-response curve compared
with lacZ control. These results suggest that the proteolyzed channel increases neuronal
sensitivity to glutamate-mediated injury and decreases the threshold for excitotoxicity.
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Capn-InsP3R1 triggers neurodegeneration of hippocampal pyramidal neurons in vivo

Since primary neuron cultures do not fully recapitulate the metabolism and
connectivity of mature neurons in vivo, we have begun to translate studies of capnInsP3R1 to an in vivo model. To examine whether calpain-cleaved InsP3R1 can cause
neurodegeneration in mature neurons in vivo without prior activation of calpain
proteolytic injury cascades, we performed stereotaxic intracerebral injections of AAV 2/1
vector expressing capn-InsP3R1 and a fluorescent marker protein (mCherry; Figure 3.6A)
into rat striatum, cortex and hippocampus (n=4; Figures 3.6B and C; Supplemental
Figure 3.4). We selected these brain regions as they contain neuron subpopulations that
are selectively vulnerable to ischemic brain injury (Neumar, 2000), a model where we
previously identified calpain-cleaved InsP3R1 in vivo (Kopil et al., 2011). The results of
these experiments are preliminary, and additional control injections of capn-InsP3R1
D2550A and mCherry controls are pending.
To determine whether expression of capn-InsP3R1 induced neurodegeneration in
vivo, we used Fluoro-Jade B to identify degenerating neurons. We performed FluoroJade staining on tissue from naïve (n=1) and mCherry injected (n=1) animals as controls.
At 3 weeks post-injection, we did not observe Fluoro-Jade labeling of capn-InsP3R1
transduced neurons in the striatum, cortex or the majority of the hippocampus. However,
expression of capn-InsP3R1 caused selective degeneration of hippocampal CA2 sector
pyramidal neurons (Figures 3.6D and E). In 3 out of 4 animals injected with AAV 2/1
expressing capn-InsP3R1 and mCherry, we observed transduction of this population of
neurons as identified by mCherry fluorescence. In 2 of those 3 animals, CA2 pyramidal
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neurons labeled with Fluoro-Jade.

To confirm these results, we performed

immunolabeling of adjacent tissue sections with an antibody targeting neuronal nuclei
(NeuN). Interestingly, in animals where we identified Fluoro-Jade positive cells, we
observed a concurrent loss of NeuN labeling in CA2 pyramidal neurons (Figures 3.6 F
and G).

We did not observe any Fluoro-Jade labeling or alterations in NeuN

immunostaining in controls. These preliminary data provide the first in vivo evidence
that expression of calpain-cleaved InsP3R1 is sufficient to induce neurodegeneration
independent of prior [Ca2+]i dysregulation or calpain activity.
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DISCUSSION
While several studies have examined the effects of InsP3R1 proteolysis on cellular
Ca2+ homeostasis (Assefa et al., 2004; Nakayama et al., 2004; Verbert et al., 2008; Kopil
et al., 2011), the current study presents the first functional investigation of calpaincleaved InsP3R1 in neurons. We have demonstrated that capn-InsP3R1 disrupts [Ca2+]i
homeostasis and decreases neuronal viability in vitro.

Impaired ER Ca2+ buffering

caused by the leaky channel also likely accounts for the increased sensitivity to
excitotoxic injury observed in primary cortical neurons expressing capn-InsP3R1.
Results from our in vivo experiments further demonstrate that capn-InsP3R1-mediated
Ca2+ signaling is sufficient to trigger neurodegeneration in specific neuronal populations.
Together, these results suggest that InsP3R1 proteolysis is a novel possible feed-forward
pathway for executing neuronal cell death.
Capn-InsP3R1 is sufficient to signal neuronal death in culture

Previous studies examining caspase- or calpain-cleaved InsP3R1 in cell lines did
not report effects of the dysregulated channel on baseline cell viability (Assefa et al.,
2004; Nakayama et al., 2004; Verbert et al., 2008; Kopil et al., 2011). This is likely due
to the relatively low open probability of the cleaved channel at resting [Ca2+]i (Kopil et
al., 2011). Unlike cell lines however, primary neurons in culture form complex networks
with spontaneous activity and neurotransmission, leading to transient increases in [Ca2+]i
(Murphy et al., 1992; Maeda et al., 1995).

Thus, we hypothesized that expression of

capn-InsP3R1 in neurons would be sufficient to signal cell death through disruption of
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neuronal Ca2+ homeostasis. To examine the effect of capn-InsP3R1 on neuronal viability,
we employed AAV mediated gene delivery to achieve high transduction efficiency in
primary cortical cultures.

We determined that expression of capn-InsP3R1 indeed

significantly decreased neuronal viability at baseline (Figure 3.2).

However, capn-

InsP3R1 expression did not lead to complete cell loss, as the majority (~65%) of capnInsP3R1-transduced neurons were viable, at least at the time studied. This likely explains
why we were unable to determine the mechanism(s) for capn-InsP3R1 induced cell death
using Western blotting (Supplemental Figure 3.1). The moderate effect of capn-InsP3R1
on baseline neuron viability may suggest gene expression heterogeneity within the
population of neurons in primary cortical cultures.

Identifying gene expression

differences and understanding their potential interactions with capn-InsP3R1 that
modulate neuronal death requires additional investigation.
Functional properties of heteroligomeric InsP3R1

Studying capn-InsP3R1 in neurons using AAV mediated gene delivery has some
limitations. Foremost, the limited packaging capacity of AAV prohibits viral vector
expression of full-length InsP3R1 as a control (Dong et al., 1996; Donnelly et al., 2001).
As an alternative control, we expressed capn-InsP3R1 with a point mutation in the
putative pore selectivity filter between transmembrane domains 5 and 6. In wt-InsP3R1,
replacing the aspartate at residue 2550 with alanine (D2550A) results in a channel that is
still able to bind InsP3 and gates normally, but lacks Ca2+ permeability and does not have
Ca2+ release activity (Boehning and Joseph, 2000; Boehning et al., 2001; Cardenas et al.,
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2010). The capn-InsP3R1 D2550A mutant channel is expected to have reduced Ca2+
conductance similar to the mutant full-length channel, but with InsP3 independent gating,
similar to capn-InsP3R1. Thus, the structure and function of capn-InsP3R1 D2550A
serves as a specific control for the effects of InsP3-independent Ca2+ release through
capn-InsP3R1.
Studying the Ca2+ permeable and impermeable capn-InsP3R1 in neurons may be
complicated by heteroligomerization of the recombinant truncated channels with
endogenous InsP3R.

At 14 DIV, we observed expression of each 95 kDa InsP3R1

constructs at an approximately 1:1 ratio with endogenous 260 kDa InsP3R1 (Figure 3.1B;
densitometry analysis not shown). Additional studies are required to fully elucidate the
stochiometry and functional properties of the different heteroligomeric channels. The
single-cell Ca2+ imaging results may provide some initial insights into the functional
properties of heteroligomeric channels. Specifically, we did not observe a reduction in
the percentage of cells with InsP3-induced Ca2+ release in capn-InsP3R1 D2550Atransduced cultures (Figure 3.3C). Nor did we observe a reduction in Ca2+ released from
InsP3 sensitive stores (Figures 3.3D and E).

Assuming that recombinant InsP3R1

subunits oligomerized with endogenous InsP3R in transduced neurons, we conclude that
expression of the D2550A mutant under the conditions of our experiments did not exert a
dominant-negative effect on Ca2+ permeability. This is consistent with theoretical models
of a similar mutation in the ryanodine receptor, where mutating a negatively charged
residue in the selectivity filter of an individual subunit resulted in only a partial decrease
in Ca2+ conductance (Gao et al., 2000; Wang et al., 2005). By analogy, we speculate that
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calpain cleavage of a single InsP3R1 subunit in the tetrameric InsP3R is unlikely to induce
an all-or-nothing effect and may be insufficient to completely eliminate the InsP3requirement for channel gating.

By studying the effects of stable capn-InsP3R1

expression in neurons with endogenous InsP3R, we are perhaps more closely modeling a
physiologically relevant process of limited proteolysis of the channel.
Neuronal Ca2+ homeostasis is disrupted by capn-InsP3R1
How does InsP3-independent Ca2+ release through capn-InsP3R1 affect neuronal
Ca2+ homeostasis?

Using single-cell Ca2+ imaging, we observed normal InsP3-induced

Ca2+ release in capn-InsP3R1 transduced cortical neurons through activation of Gq
coupled mGluR1 and mGluR5 receptors (Figures 3.3B and D-E) (Conn and Pin, 1997;
Fagni et al., 2000).

This result is consistent with previous reports showing that

expression of caspase- or calpain-cleaved InsP3R1 does not deplete [Ca2+]ER, even though
it increases the rate of ER Ca2+ leak (Assefa et al., 2004; Verbert et al., 2008; Kopil et al.,
2011). This increased ER Ca2+ leak in neurons expressing capn-InsP3R1 was manifested
as elevated resting [Ca2+]i (Figures 3.3B and 3.4B, Supplemental Figure 3.2B). While the
resting [Ca2+]i was variable across experiments performed on cortical cultures from
different embryos and platings, the ~20 nM increase in [Ca2+]i in capn-InsP3R1transduced neurons versus controls remained consistent. This elevated resting [Ca2+]i
suggests that capn-InsP3R1 generates an ER Ca2+ leak that can not be fully compensated
for by other Ca2+ transport mechanisms. This is in contrast to our previous data from
Neuro-2A cells, where we did not detect any effect of capn-InsP3R1 on resting [Ca2+]i
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(Kopil et al., 2011). The elevated basal [Ca2+]i observed here could be a cell-type
specific effect, or a consequence of chronic capn-InsP3R1 expression, as our previous
study examined changes in [Ca2+]i at 6 h post-transfection.

In either case, chronic

elevations in resting [Ca2+]i may explain the decreased neuronal viability in primary
cortical cultures expressing capn-InsP3R1.
The apparent increased ER Ca2+ leak through capn-InsP3R1 resulted in more
pronounced changes in neuronal [Ca2+]i in response to Ca2+ influx. Expression of capnInsP3R1 significantly increased the peak [Ca2+]i response to glutamate (Figure 3.4C).
This likely reflects a decreased capacity of normal ER Ca2+ buffering in neurons
expressing capn-InsP3R1. The kinetics of the glutamate Ca2+ responses were also altered
in capn-InsP3R1-transduced cultures.

[Ca2+]i in lacZ- and capn-InsP3R1 D2550A-

transduced neurons rapidly reached a plateau after the initial rise, whereas [Ca2+]i in
capn-InsP3R1-transduced neurons continued to rise until glutamate was removed from the
bath (Figure 3.4A).

Interestingly, average peak [Ca2+]i in capn-InsP3R1 expressing

neurons approached 2 µM, which is optimal [Ca2+]i for wt-InsP3R1 and capn-InsP3R1
activation (Foskett et al., 2007; Kopil et al., 2011). We expect that increased channel
open probability of capn-InsP3R1 at this higher [Ca2+]i compromises ER Ca2+ buffering,
and provides a potential mechanism for increased sensitivity to glutamate injury (Figure
3.5) through irreversible disruption of neuronal Ca2+ homeostasis.
It is important to note that we measured somatic [Ca2+]i. in these experiments. As
neuronal dendritic and synaptic structure is complex, with heterogeneous distributions of
ER and InsP3R (Bardo et al., 2006; Stutzmann and Mattson, 2011), capn-InsP3R1 may
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exert varying influences in these cellular compartments. Understanding the spatial
complexity and functional consequences of capn-InsP3R1-mediated Ca2+ signaling in
dendrites and synapses warrants future investigation.
Role of calpain-cleavage of InsP3R1 in neurodegeneration
Sustained pathological rises in [Ca2+]i are a key component of both apoptotic and
necrotic cell death (Berridge et al., 2000; Orrenius et al., 2003; Mattson, 2007).
Therefore, we hypothesized that the dramatic glutamate-induced rise in [Ca2+]i in capnInsP3R1 expressing primary cortical neurons would increase their sensitivity to
excitotoxic injury. We tested this by exposing transduced cultures to glutamate rather
than NMDA, as expression of pathogenic NMDA receptor subunits is developmentally
regulated in primary neurons (O'Donnell et al., 2006) and glutamate produced a more
consistent, dose-dependent injury in untransduced 14 DIV cultures.4

As predicted,

expression of capn-InsP3R1 significantly decreased the percentage of surviving neurons
over a range of glutamate concentrations (Figure 3.5). Enhanced glutamate-induced cell
death is likely precipitated by Ca2+-induced Ca2+ release through capn-InsP3R1 in
addition to decreased basal ER Ca2+ buffering in these cells. Together, these impairments
of neuronal Ca2+ homeostasis increase sensitivity to excitatory stimuli, leading to [Ca2+]i
overload. The downstream effects of this [Ca2+]i overload may signal cell death through
either necrotic or apoptotic pathways. Sustained elevations of [Ca2+]i could directly lead
to pathologic activation of calpains and calpain-mediated cell death (Goll et al., 2003;
4

C.M. Kopil, A.P. Siebert, J.K. Foskett and R.W. Neumar, unpublished observation.
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Vosler et al., 2008). Alternatively, [Ca2+]i overload could enhance mitochondrial Ca2+
uptake triggering mitochondrial permeability transition and caspase-mediated apoptosis
(Orrenius et al., 2003; Taylor et al., 2008).

Future mechanistic studies are required to

clarify the precise pathologic pathway(s) activated by capn-InsP3R1-mediated Ca2+
signaling. However, current available data suggest that calpain proteolysis of InsP3R1 in
neurons acts to activate and accelerate cell death pathways after injury through [Ca2+]i
overload.
To fully elucidate the role of capn-InsP3R1-mediated Ca2+ signaling in
neurodegeneration, we have begun translating experiments from primary cortical cultures
to mature neurons in the brain. Although we transduced neurons in the striatum, cortex
and hippocampus, capn-InsP3R1 expression only caused obvious neurodegeneration in a
subpopulation of hippocampal neurons (Figures 3.6D-G; Supplemental Figure 3.4) at the
time examined. This preliminary result provides the first in vivo evidence that capnInsP3R1 expression is sufficient for signaling neuronal death without upstream disruption
of Ca2+ homeostasis or prior calpain activation. The apparent selective vulnerability of
hippocampal CA2 pyramidal neurons raises a number of interesting questions,
particularly because of the dearth of information about these cells compared with CA1
and CA3 pyramidal cells.

Molecular profiling has emerged as a useful tool for

distinguishing between CA subregions and may be the most definitive way to identify
CA2 pyramidal neurons (Zhao et al., 2001; Lein et al., 2004; Lein et al., 2007).
molecular

characteristics

that

confer

susceptibility
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to

The

capn-InsP3R1-mediated

neurodegeneration in CA2 neurons are a subject for future investigations, and priority
should be devoted to studying genes related to Ca2+ signaling in these cells.
Conclusions

In summary, our results indicate that expression of calpain-cleaved InsP3R1
impairs neuronal ER Ca2+ buffering, leading to increased sensitivity to excitotoxic stimuli
and neurodegeneration in vitro and in vivo. As an early part of the molecular injury
pathway (Kopil et al., 2011), calpain proteolysis of InsP3R1 could contribute a feedforward pathway to accelerate neuronal death through [Ca2+]i overload. Thus, inhibiting
Ca2+ release through calpain-cleaved InsP3R1 is a potentially important therapeutic
strategy for intervention in disorders associated with calpain activity and disruption of
Ca2+ homeostasis.
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MATERIALS AND METHODS
Materials—Unless otherwise noted, all chemicals were purchased from SigmaAldrich (USA).
Antibodies—Rabbit polyclonal antibody targeted against the 20 carboxyl-terminal
residues of rat InsP3R1 was generated using previously described methods (Joseph and
Samanta, 1993; Kopil et al., 2011) (Covance ImmunoTechnologies). Rabbit polyclonal
antibody to MAP2 was a gift from Dr. Virginia Lee (University of Pennsylvania). Mouse
monoclonal antibody to BiP/GRP78 was purchased from BD Biosciences. Mouse
monoclonal antibody to α-spectrin (Ab1622) was purchased from Chemicon
International. Mouse monoclonal antibody to NeuN (MAB377) was purchased from
Millipore. Alexa Fluor 488- and Alexa Fluor 568-conjugated secondary antibodies used
for immunofluorescence were purchased from Invitrogen. Horseradish peroxidase-linked
secondary antibodies used for immunoblotting were purchased from Perkin Elmer.
Rat Primary Mixed Cortical Cultures—Rat primary cortical neurons were
cultured using standard technique described previously (Cummings et al., 1996). Briefly,
cortices from E19 Sprague-Dawley rat embryos were trypsinized in Dulbecco’s minimum
essential medium (DMEM; Whittaker Bioproducts) at 4ºC for 20 min.

Cells were

triturated in media consisting of DMEM supplemented with 10% bovine calf serum
(Hyclone), 10% Ham’s F12 with glutamine (Whittaker Bioproducts), and 50 U/ml
penicillin-streptomycin.

Dissociated cortical cultures were plated on poly-L-lysine

coated 35-mm dishes (400,000 cells/mL; Western blot), 12-mm glass coverslips in 24well plates (200,000 cells/mL; immunofluorescence), or 20 X 50-mm glass coverslips in
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4-well plates (800,000 cells/mL; single-cell Ca2+ imaging). Dissociated cells were grown
in serum-free Neurobasal medium (Gibco) supplemented by B27 (Gibco) and cultured at
37ºC in a humidified 5% CO2 incubator. Mitotic inhibitors and antibiotics were not used.
Constructs and Site Directed Mutagenesis—The transgene for rat calpain-cleaved
InsP3R1 (capn-InsP3R1; Figure 3.1A) was previously generated (Kopil et al., 2011). To
construct the inactivating D2550A pore mutation (capn-InsP3R1 D2550A), site-directed
mutagenesis was performed with QuikChange (Stratagene) using primers (5’–
GGCGGAGTAGGAGCTGTGCTCAGGAAG–3’

and

5’–

CTTCCTGAGCACAGCTCCTACTCCGCC–3’ (codon change is shown in boldface
type and underlined)) and capn-InsP3R1 as a template. The mutation was confirmed by
DNA sequencing. For transduction of primary neurons, both capn-InsP3R1 and capnInsP3R1 D2550A were subcloned into a plasmid containing the AAV inverted terminal
repeats (ITRs) and polyA sequence for viral vector generation. For transduction of
neurons in vivo, we utilized an AAV plasmid containing a cis-acting hydrolase element
(CHYSEL) to create vectors with bicistronic expression of transgenes and a marker
protein (mCherry) from a single transcript. The CHYSEL sequence contains a canonical
DVIEXNPG(2A)P(2B) motif, which results in cleavage between the 2A glycine and 2B
proline (Donnelly et al., 2001; de Felipe et al., 2003; Szymczak et al., 2004).
Viral Vector Generation—Recombinant AAV vectors were generated by the
University of Pennsylvania Vector core as previously described (Fisher et al., 1997).
Briefly, AAV vectors were prepared by triple transfection of HEK293 cells and purified
by cesium chloride gradient sedimentation. AAV 2/1 vectors were designed to express
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capn-InsP3R1, capn-InsP3R1 D2550A or lacZ control. All transgenes were expressed
under the control of the cytomegalovirus promoter (CMV).
AAV 2/1 Vector Transduction of Primary Neurons—Rat primary cortical cultures
were transduced at 7 DIV by adding AAV 2/1 vector in a vehicle of phosphate-buffered
saline (PBS) with 10% glycerol directly to the culture media. Cultures were transduced
with 7.5 x 1010 genome copies (GC) per mL.

All cell viability, biochemical, and

functional assays were performed 1 week later (14 DIV).
Cell Viability Assays—Transduced cultures were fixed with 4% paraformaldehyde
(PFA), immunolabeled for the neuronal marker MAP2 with a goat anti-rabbit secondary
antibody (Alexa Fluor 568), and counterstained with 4,6-diamidino-2-phenylindole
(DAPI) nuclear label (Vector Laboratories). Five random 100X images were taken from
each 12-mm coverslip. The number of surviving MAP2-labeled neurons per coverslip
was estimated by blinded counting of all captured fields.

For each transduction

condition, 8 to 12 coverslips were counted from 2 or more independent experiments. To
control for variability in culture health between experiments, the percentage of viable
cells was determined by normalizing to the average cell count from lacZ transduced
cultures for each independent experiment. The average of the normalized experiments is
shown. Reported SE and error bars reflect propagated error through normalization.
Cell viability was independently measured by staining cultures with calcein-AM
and PI (Invitrogen). Live cultures were incubated with 3 µM calcein-AM and 5 µM PI in
Dulbecco’s PBS (DPBS; Gibco) for 30 min at 37ºC and 5% CO2. Cultures were rinsed
with DPBS and immediately imaged. Five random 100X images were taken from each
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12-mm coverslip. The number of surviving, calcein-AM-positive, PI-negative cells per
coverslip was estimated by blinded counting of all captured fields. For each transduction
condition, 6 to 14 coverslips were counted from 2 or more independent experiments. The
number of viable cells in each transduction condition was normalized to lacZ controls as
described above.
Western Blotting of Primary Neuron Cultures—Media was removed from
transduced cultures and replaces with 4ºC DPBS. Cells were harvested by scraping and
resuspended in homogenization buffer (50 mM Tris, 150 mM NaCl, 2 mM EGTA) with a
protease inhibitor cocktail and sonicated. Lysates were treated with SDS loading buffer,
boiled and analyzed on SDS-PAGE gels. Western blots were visualized using enhanced
chemiluminescence supplies purchased from Perkin Elmer.

Protein and polypeptide

densities were quantified by computer densitometry (ImageJ) and normalized to lacZ
controls.
Single-Cell Ca2+ Imaging—Cortical cultures were plated onto glass-coverslips
(Warner Instruments) and transduced with AAV 2/1 at 7 DIV. One week following
transduction, cells on coverslips were secured in a perfusion chamber, and mounted on
the stage of an inverted microscope (Nikon Eclipse TE2000). Cells were loaded with
Fura-2-AM (Molecular Probes; 2.5 µM) for 45 min at 37ºC and 5% CO2 in Ca2+containing extracellular solution (in mM: 120 NaCl, 4 KCl, 20 HEPES, 15 Glucose, 2
CaCl2, 1 MgCl2, pH 7.3). Fura-2 was alternately illuminated at 340/380 nm, and
fluorescence intensity filtered at 510 nm. Data were collected and recorded as described
previously (White et al., 2005; Cheung et al., 2008). Cells were perfused with 2 mM
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Ca2+ extracellular solution to establish baseline [Ca2+]i before glutamate (10 µM), KCL
(50 mM), or DHPG (10 µM) was applied in the extracellular solution. At the end of the
experiment, Mn2+ was used to quench Fura-2 fluorescence (Ca2+-containing extracellular
solution supplemented with 10 mM MnCl2 and 10 µM ionomycin). The remaining
background fluorescence following Mn2+ quench was subtracted during analysis. Glial
cells were identified by enhanced Fura-2 loading and morphological characteristics, and
were excluded from analysis.

Experiments using glutamate, KCL and DHPG were

performed on different weeks, in cultures from different platings.

Within each

experiment using either glutamate, KCl or DHPG however, the studied lacZ, capnInsP3R1 D2550A and capn-InsP3R1 transduced cultures were derived from the same
plating.
Changes in [Ca2+]i are presented as changes in fluorescence ratio. Dye calibration
was achieved by applying experimentally determined constants to the equation: [Ca2+] =
Kd β(R–Rmin)/(Rmax–R). Macros used for analysis were custom macros written for IGOR
Pro (WaveMetrics).
Glutamate Injury Characterization—HBS (in mM: 145 NaCl, 3 KCl, 10 HEPES,
8 Glucose, 2 CaCl2, 1 MgCl2, pH 7.4) with or without L-glutamic acid was added to the
media of transduced cortical cultures at 14 DIV.

Twenty-four hours after HBS or

glutamate application, cultures were fixed with 4% PFA, immunolabeled for MAP2, and
counter-stained with DAPI. Five random 100X images were taken from each 12-mm
coverslip. The number of surviving MAP2-labeled neurons per coverslip was estimated
by blinded counting of all captured fields. For each transduction condition, 6 to 8
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coverslips were counted from 2 or more independent experiments. To control for
variability in culture health between experiments and differences in baseline toxicity, the
percent of viable cells at each glutamate dose was determined by normalizing within
transduction conditions to the average cell count from HBS treated cultures. Data were
normalized within independent experiments and the average of the normalized
experiments is shown. Reported SE and error bars reflect propagated error through
normalization. Dose response curves were calculated by fitting plotted mean data points
using the Hill equation and holding the base and max values at 0 and 100 respectively.
Reported error for LD50 values represent error of the fit.
Viral Vector Injection—Intracranial injection of AAV 2/1 vectors was performed
as described previously (Bevers et al., 2010). Briefly, male rats weighing 375-425 g were
anesthetized by inhalation of 4% isoflurane in 70% O2 and 30% N2O and a surgical plan
of 2% isoflurane. A longitudinal surgical incision in the scalp was made and the skull
exposed by blunt dissection. Bilateral burr holes were centered 2.6 mm lateral to the
midline and 1.6 mm caudal to Bregma (for striatum and overlying cortex) and 2.0 mm
lateral to the midline and 3.8 mm caudal to Bregma (for hippocampus and overlying
cortex). Sterotaxically-guided injections were made at depths of 4.4 mm (striatum), 3.0
mm (hippocampus), and either 1.0 or 1.8 mm (cortex) below the dural surface. At each
site, 2 µl of AAV 2/1 vector solution (1 x 1010 GC total) was infused at a rate of 0.5
µl/min. After injection, the needle was held in place for 5 min and then removed slowly
over 2 min. The scalp was sutured closed and rats recovered.
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Immunohistochemical Staining of Rat Forebrain—At 3 weeks post-intracranial
vector injection, rats were anesthetized with pentobarbital (200 mg/kg) and transcardially
perfused with cold PBS (pH 7.4) followed by 4% PFA in 0.1M phosphate buffer (PB).
Brains were extracted, post-fixed in 4% PFA for 4 h and cryoprotected using serial
incubations in 0.1 M PB containing 10%, 20% and 30% sucrose. Serial coronal sections
through the forebrain (40 µm) were cut on a freezing sliding microtome. Sections were
immunolabeled with primary antibody targeting the neuron-specific marker protein NeuN
and a goat anti-mouse secondary antibody (Alexa Fluor 488). Sections were
counterstained with Hoechst (5 µg/mL) and mounted with Fluoromount medium
(Electron Microscopy Sciences).
For Fluoro-Jade labeling, PFA-fixed sections were processed as described
previously (Kopil et al., 2011).

As Fluoro-Jade labeling decreased mCherry

fluorescence, tissue was mounted, temporarily coversliped with water and imaged for
expression of mCherry.

Coverslips were then removed, and hydrated tissue was

incubated with 0.06% potassium permanganate for 10 min, rinsed with dH2O, and stained
with 0.0004% Fluoro-Jade B (Millipore) in 0.1% acetic acid for 20 min. Stained tissue
was rinsed with dH2O, dried at 37°C, dehydrated with xylene and coversliped using
Permount (Fisher Scientific).
Data analysis and statistics— Data are presented as the mean ± SE, and statistical
significance of differences between the means was assessed using either unpaired t-tests
or analysis of variance for repeated-measures using Barlett’s test for equal variances and
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a Bonferroni correction.

Differences between means were accepted as statistically

significant at the 95% level (p < 0.05).
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FIGURES AND LEGENDS

Figure 3.1

Figure 3.1 Schematic representation and expression of recombinant InsP3R1 constructs in primary
neurons
(A) Protein domain structure of wt-InsP3R1 (top), calpain-cleaved InsP3R1 (middle), and calpain-cleaved
InsP3R1 with the D2550A point mutation (bottom; red arrowhead). Residues numbered according to rat
type 1 SI+, SII+, SIII- sequence (protein accession NP_001007236.1). (B) Western blot analysis of whole
cell lysates from untransduced rat primary cortical cultures and primary cortical cultures transduced with
AAV 2/1 expressing lacZ, capn-InsP3R1 D2550A, or capn-InsP3R1 at 1 week post-transduction (14 DIV).
Carboxyl-terminal InsP3R1 antibody was used to detect endogenous and recombinant truncated rat
InsP3R1. Antibody against actin was used as a loading control.
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Figure 3.2

Figure 3.2 Primary cortical neuron viability is reduced by expression of capn-InsP3R1
Rat primary cortical cultures were transduced with AAV 2/1 expressing lacZ, capn-InsP3R1 D2550A, or
capn-InsP3R1 (7 DIV). (A) One week following transduction (14 DIV), cultures were stained for MAP2
(red) and nuclei (blue; left panel), or incubated with calcein-AM (green) and PI (red; right panel).
Representative 100X epifluorescence images captured for counting are shown. (B) Percent neuronal
survival as determined by counts of MAP2 reactive cells (one-way analysis of variance; *, p<0.001). (C)
Percent cell survival as determined by counts of calcein-AM positive, PI-negative cells (unpaired t tests
with unequal variance; *, p<0.001). Expression of capn-InsP3R1 resulted in a significant decrease in the
percentage of viable neurons compared with lacZ and capn-InsP3R1 D2550A as determined by both assays.
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Figure 3.3

Figure 3.3 Capn-InsP3R1 does not deplete InsP3-sensitive stores
(A) Representative single cell [Ca2+]i responses to DHPG in Fura-2 loaded primary cortical neurons (14
DIV) transduced with lacZ (green), capn-InsP3R1 D2550A (blue) or capn-InsP3R1 (red). (B) Summary of
average resting [Ca2+]i in neurons from cultures used for DHPG Ca2+ imaging experiments. Neurons
expressing capn-InsP3R1 demonstrate increased resting [Ca2+]i (unpaired t-tests with unequal variance; *,
p<0.001). (C) Percentage of neurons in transduced cortical cultures that exhibited >10% increase in [Ca2+]i
in response to DHPG. (D) Summary of average peak [Ca2+]i responses elicited by DHPG. (E) Summary of
average change in [Ca2+]i from resting to peak [Ca2+]i. Despite significant differences in resting [Ca2+]i in
these experiments, no statistical differences were observed in average change in [Ca2+]i.
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Figure 3.4

Figure 3.4 Neurons expressing capn-InsP3R1 have increased glutamate-induced rises in [Ca2+]i
(A) Averaged single-cell [Ca2+]i responses to glutamate in Fura-2 loaded primary cortical neurons (14 DIV)
transduced with lacZ (green), capn-InsP3R1 D2550A (blue) or capn-InsP3R1 (red). (B) Summary of
average resting [Ca2+]i in neurons from cultures used for glutamate Ca2+ imaging experiments. Expression
of capn-InsP3R1 significantly increased resting [Ca2+]i in neurons (108.2 ± 2.6 nM) compared with capnInsP3R1 D2550A (81.0 ± 2.5 nM) and lacZ controls (87.3 ± 2.6 nM; unpaired t-tests with unequal variance;
*, p<0.001). (C) Summary of average peak [Ca2+]i responses elicited by glutamate shows an increased
maximum [Ca2+]i achieved in capn-InsP3R1 expressing neurons (unpaired t-tests with unequal variance; *,
p<0.001).
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Figure 3.5

Figure 3.5 Expression of capn-InsP3R1 increases neuronal susceptibility to glutamate-mediated
injury
(A) Transduced primary cortical cultures (14 DIV) were exposed to 1 µM glutamate or HBS vehicle.
Twenty-four hours later, cultures were stained for MAP2 and percent neuronal survival quantified relative
to vehicle treated cultures. Expression of capn-InsP3R1 resulted in a significant decrease in percentage of
MAP2-positive cells following glutamate injury compared with lacZ and capn-InsP3R1 D2550A (one-way
analysis of variance; *, p<0.01). (B) Glutamate dose-response curves for lacZ and capn-InsP3R1
transduced cultures (data at 1 µM glutamate are the same as shown in Figure 3.5A). Expression of capnInsP3R1 significantly decreased the percentage of MAP2-positive cells following treatment with 0.3, 0.5,
and 1 µM glutamate compared with lacZ (unpaired t tests; *, p<0.01) and resulted in a shift in the
glutamate-dose response curve. LD50 for glutamate in neurons expressing capn-InsP3R1 (0.75 ± 0.19 µM)
is reduced compared with neurons expressing lacZ (2.61 ± 0.78 µM).
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Figure 3.6

Figure 3.6 Expression of capn-InsP3R1 causes neurodegeneration in subpopulations of hippocampal
neurons in vivo.
(A) Vector design for transduction of neurons in vivo. Plasmid contains AAV-specific ITRs for vector
generation and a CHYSEL sequence (T2A) for bicistronic expression of capn-InsP3R1 and mCherry. (B)
mCherry expression in rat hippocampus 3 weeks after injection of AAV 2/1 vector shown in A.
Hippocampal neurons in CA1, CA2, and CA3 were transduced in this animal. (C) Higher magnification of
region highlighted in B (white box). Closed arrow indicates CA2 region, open arrow indicates CA3 region.
(D) Fluoro-Jade labeling of adjacent tissue section. Degenerating neurons were identified in the CA2
region. (E) Region highlighted in D at higher magnification shows shrunken somatic morphology of
Fluoro-Jade positive cells consistent with neurodegeneration. (F) Immunostaining of adjacent tissue
section using NeuN (green) to label neurons. mCherry (red) expression identifies transduced cells. FluoroJade positive region shown in D does not label with NeuN. (G) Region highlighted in F at higher
magnification shows loss of NeuN labeling and presence of red debris. Expression of capn-InsP3R1 in vivo
leads to selective neurodegeneration of CA2 hippocampal neurons in the pyramidal layer.
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SUPPLEMENTAL DATA

Supplemental Figure 3.1

Supplemental Figure 3.1 Activation of ER stress markers and proteases in transduced primary
cortical neurons
Western blot analysis of whole cell lysates from primary cortical cultures transduced with AAV 2/1
expressing lacZ, capn-InsP3R1 D2550A, or capn-InsP3R1 at 1 week post-transduction (14 DIV). (A)
Antibody against BiP was used to detect activation of ER stress response. Untransduced cultures were
treated with thapsigargin (Tg; 1 µM) as a positive control for ER stress and increased BiP. Antibody against
actin was used as a loading control. (B) BiP band densities were quantified and normalized to actin.
Changes in protein expression are expressed relative to lacZ controls. (C) Antibody against α-spectrin was
used to detect calpain- and caspase-mediated proteolysis. Calpain-mediated cleavage of α-spectrin (260
kDa) generates 150 and 145 kDa polypeptides while caspase-mediated cleavage generates 150 and 120 kDa
polypeptides. (D) Full-length (260 kDa) and proteolyzed (145/150 kDa and 120 kDa) α-spectrin band
densities were quantified and normalized to actin. Changes in intact α-spectrin and α-spectrin fragment
densities are expressed relative to lacZ controls. There are no statistically significant differences between
BiP or α-spectrin band densities in lacZ-, capn-InsP3R1 D2550- and capn-InsP3R1-transduced cultures.
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Supplemental Figure 3.2

Supplemental Figure 3.2 Neurons expressing capn-InsP3R1 have increased rises in [Ca2+]i in response
to depolarization
(A) Averaged single-cell [Ca2+]i responses to depolarization with 50 mM KCl in Fura-2 loaded primary
cortical neurons (14 DIV) transduced with lacZ (green) or capn-InsP3R1 (red). (B) Summary of average
resting [Ca2+]i in neurons from cultures used for KCl Ca2+ imaging experiments. Consistent with data
presented in Figures 3.4B and 3.5B, cultures expressing capn-InsP3R1 demonstrate increased baseline
[Ca2+]i (capn-InsP3R1=96.7 ± 3.5 nM, lacZ=76.2 ± 2.9 nM; unpaired t-tests with unequal variance; *,
p<0.001). (C) Summary of average peak [Ca2+]i responses elicited by KCl shows an increased maximum
[Ca2+]i achieved in capn-InsP3R1 expressing neurons (capn-InsP3R1=1540 ± 73 nM, lacZ=1035 ± 65 nM;
unpaired t-tests with unequal variance; *, p<0.001).
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Supplemental Figure 3.3

Supplemental Figure 3.3 Characterization of glutamate injury model
(A) Untransduced rat primary cortical cultures (14 DIV) were exposed to HBS vehicle or 1, 5, 10 or 50 µM
glutamate. Twenty-four hours later, cultures were stained for MAP2 and percent neuronal survival
quantified relative to vehicle treated controls. The percentage of surviving cells was significantly reduced
in cultures treated with glutamate concentrations > 5 µM (1 µM=91.5 ± 10.6 %, 5 µM=38.3 ± 4.4 %,
10µM=13.9 ± 3.7 %, 50µM=4.3 ± 2.6 %; one-way analysis of variance; *, p<0.01). LD50 for glutamate in
these cultures is 3.49 ± 0.48 µM.
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Supplemental Figure 3.4

Supplemental Figure 3.4 CA1 neurons tolerate expression of capn-InsP3R1
(A) Representative image (100X) of immunostained rat hippocampus 3 weeks after injection of AAV 2/1
vector expressing capn-InsP3R1 and mCherry. CA1 pyramidal neurons were robustly transduced in this
animal as evidenced by mCherry expression in the soma, and apical and basal dendrites (top). NeuN
labeling (center) demonstrates healthy neurons in CA1 pyramidal layer. (B) Fluoro-Jade staining of an
adjacent tissue section reveals no evidence of degeneration in CA1 pyramidal layer (closed arrow). These
data provide evidence that expression of capn-InsP3R1 is well tolerated by certain neuronal populations.
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DISCUSSION

Ischemic brain injury resulting from cardiac arrest represents a major cause of
severe cognitive impairment, disability and death. The molecular mechanisms of delayed
neuronal death following ischemia-reperfusion remain incompletely understood. The
work described in the previous chapters extends our understanding of how both calpain
and disruption of neuronal Ca2+ homeostasis contribute to neuropathology resulting from
ischemia. In this thesis, we present data that demonstrate calpain proteolysis of type 1
inositol 1,4,5-trisphosphate receptor (InsP3R1) generates a leaky channel that impairs
normal Ca2+ buffering by the endoplasmic reticulum (ER) and may contribute to neuronal
death following ischemic brain injury. Specifically, in Chapter 2, we identified the
precise cleavage site responsible for generating the stable carboxyl-terminal channel
fragment of InsP3R1, and determined that the cleaved channel has InsP3-independent
gating and constitutive activity. The calpain-cleaved form of InsP3R1 decreased Ca2+
content of intracellular stores via increased ER Ca2+ leak. Importantly, we provided the
first evidence of calpain-mediated proteolysis of InsP3R1 in vivo, which we identified in
selectively vulnerable cerebellar Purkinje neurons at early and late time points after
cardiac arrest. Following these studies, we proceeded, in Chapter 3, to examine the
functional consequences of calpain-cleaved InsP3R1 on neuronal Ca2+ homeostasis and
survival. We found that expression of truncated InsP3R1 decreased neuronal viability in
primary cultures, dramatically altered intracellular Ca2+ homeostasis, and increased
sensitivity to excitotoxic injury. Finally, we began translation of these studies in vivo,
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where we observed degeneration of CA2 hippocampal neurons induced by expression of
calpain-cleaved InsP3R1 without prior injury. Together, these findings support the novel
role of InsP3R1 proteolysis in post-ischemic neuronal death and expand our
understanding of cell death pathways in neurodegenerative diseases associated with
pathological protease activation and disruption in Ca2+ homeostasis.
Calcium Signaling Through Calpain-cleaved InsP3R1
Our functional studies of calpain-cleaved InsP3R1 raise important questions for
future research into Ca2+ signaling through the proteolyzed channel. First, the InsP3independent gating of recombinant calpain-cleaved InsP3R1 (capn-InsP3R1; Chapter 2)
suggests that proteolysis induces a shift in channel function from InsP3-induced Ca2+
release (IICR) to Ca2+-induced Ca2+ release (CICR). The combination of IICR and CICR
through InsP3Rs normally coordinates propagation of Ca2+ signals by facilitating
activation of neighboring clusters of InsP3Rs (Berridge, 1997; Foskett et al., 2007).
Under physiological conditions, this Ca2+ signaling is regulated by 1) the InsP3
requirement for channel gating, and 2) channel inactivation by high cytoplasmic free Ca2+
concentration ([Ca2+]i).

In pathological states where calpain cleaves InsP3R1, the

truncated channel no longer depends on InsP3 for activation, and while the biphasic Ca2+
regulation of the channel stills exists, this may not be enough to prevent aberrant CICR.
Cytoplasmic diffusion of Ca2+ released through InsP3R is typically spatially
restricted, resulting in microdomains of elevated [Ca2+]i that decrease with distance from
the channel pore. [Ca2+]i adjacent to an open InsP3R channel may reach 100 µM or more,
whereas 1 or 2 µM from the pore, the concentration steeply decreases to only 1 µM
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(Neher, 1998). Interestingly, high [Ca2+]i (25 µM; Chapter 2) reduces capn-InsP3R1
channel open probability (Po), however [Ca2+]i in the low micromolar range is, in fact,
optimal for capn-InsP3R1 gating (Chapter 2).

Thus, InsP3R clustering and spatial

organization of capn-InsP3R1-mediated Ca2+ release may lead to continuous unregulated
CICR.

Additional experiments are required to characterize spatial domains of Ca2+

released by capn-InsP3R1. Flash photolysis of caged Ca2+ provides a tool for uniformly
elevating [Ca2+]i, which has been helpful in characterizing CICR properties of ryanodine
receptors (RyR) (Shirokova and Niggli, 2008). This technique, in combination with
dantrolene to block RyR-mediated Ca2+ release, could potentially elucidate the
characteristics and global effects of CICR within neurons expressing capn-InsP3R1.
In addition to causing a shift from IICR to CICR, calpain proteolysis of the
amino-terminus of InsP3R1 potentially alters normal receptor degradation pathways.
InsP3R1 expression can be down-regulated in an activity-dependent fashion by
ubiquitination and proteasomal degradation (Wojcikiewicz, 2004). Chronic activation of
G-protein coupled receptors linked with generation of InsP3, as well as Ca2+ release
through InsP3R1 can cause ubiquitination of the channel (Alzayady and Wojcikiewicz,
2005; Bhanumathy et al., 2006). Thus, chronic Ca2+ release through calpain-cleaved
InsP3R1 may be a signal for ubiquitination.

Recent data using mass spectrometric

analysis has identified 11 lysine residues within InsP3R1 that can be ubiquitinated (Sliter
et al., 2008). Based on the InsP3R1 cleavage site we identified (Chapter 2), calpain
proteolysis of the channel removes 8 of the 11 potential sites for ubiquitination.
Additionally, calpain proteolysis removes all of the polyubiquitination sites in the amino112

terminus of InsP3R1 (Bhanumathy et al., 2006; Sliter et al., 2008), which are required for
proteasomal degradation (Hicke, 2001; Ikeda and Dikic, 2008). While the functional
significance of monoubiquitination of InsP3R1 is unclear, these data suggest that calpaincleaved InsP3R1 cannot be targeted for proteasomal degradation, despite its constitutive
activity. Thus, calpain cleavage of InsP3R1 may be critical to executing cell death by
removing activity dependent regulation of the channel thereby causing Ca2+ overload.
Our studies of calpain-cleaved InsP3R1 that demonstrate disrupted intracellular
Ca2+ homeostasis also raise questions about Ca2+-induced remodeling of Ca2+ signaling.
Ca2+ itself is a potent activator of gene transcription, and InsP3R-mediated Ca2+ signaling
is an important component of that process (Mellstrom and Naranjo, 2001; Berridge et al.,
2003). Substantial evidence supports the role of Ca2+-dependent transcription of Ca2+
regulatory proteins as a feedback mechanism for maintaining cellular Ca2+ homeostasis.
Capn-InsP3R1-mediated Ca2+ signaling may alter these pathways.

Elevated resting

[Ca2+]i, as seen in neurons expressing capn-InsP3R1 (Chapter 3), is known to decrease
neuronal excitability through Ca2+-activated K+ channels (Fakler and Adelman, 2008).
However, previous data demonstrated that cultured neurons transfected with an inwardly
rectifying K+ channel eventually recover normal firing rates despite continued channel
expression (Burrone et al., 2002).

This suggests that compensatory alterations in

expression of other genes occur to maintain an ideal level of neuronal excitability
(Turrigiano, 2008). A similar compensatory mechanism may be activated by proteolyzed
InsP3R1, which could potentially lead to pathologically increased sensitivity to excitatory
stimulation. Alternatively, Ca2+ signaling through calpain-cleaved InsP3R1 may trigger
113

cell death if compensatory changes in other Ca2+ regulatory proteins are insufficient to
restore normal spatiotemporal properties of neuronal Ca2+ signaling.
Future investigation of these Ca2+-induced Ca2+ signaling remodeling processes
may provide important insights into post-ischemic changes in gene expression in
vulnerable neurons. Currently identified alterations in post-ischemic gene expression
include changes in NMDA and AMPA glutamate receptor (Pellegrini-Giampietro et al.,
1992; Pellegrini-Giampietro et al., 1994; Gorter et al., 1997; Zhang et al., 1997; Gascon
et al., 2005; Liu et al., 2010), and voltage-gated Ca2+ channel expression (Chung et al.,
2001a; Chung et al., 2001b).

If these changes in expression are a downstream

consequence of aberrant Ca2+ release through calpain-cleaved InsP3R1, then blocking the
truncated channel may prove to be neuroprotective.
How can Ca2+ release through calpain-cleaved InsP3R1 be blocked? Heparin is an
effective inhibitor of wild type (wt) InsP3R (Ghosh et al., 1988). However, it acts as a
competitive inhibitor of InsP3 binding, and therefore does not block capn-InsP3R1
(Chapter

2).

Another

InsP3R

antagonist

is

the

membrane

permeant

2-

aminoethoxydiphenyl-borate (2-APB) (Maruyama et al., 1997; Bilmen and Michelangeli,
2002). Unlike heparin, 2-APB does not prevent InsP3 binding to the receptor. Instead, it
more likely acts as an allosteric inhibitor (Bilmen and Michelangeli, 2002) and may be
able to block calpain-cleaved InsP3R1. Unfortunately, 2-APB is not a specific inhibitor
of InsP3R, and has also been shown to target store operated channels (Bootman et al.,
2002; Park et al., 2002), the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA)
(Bilmen et al., 2002; Peppiatt et al., 2003), and transient receptor potential channels (Hu
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et al., 2004). Another potentially useful InsP3R blocker is xestospongin (Xe). Several
forms of Xe have been used to specifically block Ca2+ release from InsP3R (Gafni et al.,
1997). Their mechanism of action has not been definitively identified although it is
speculated that XeB acts at an allosteric site on InsP3R.5 The potent inhibition of wtInsP3R-mediated Ca2+ release by XeB warrants examining the effects on calpain-cleaved
InsP3R1.

Single-channel electrophysiology and single-cell Ca2+ imaging experiments

using cultured cells expressing capn-InsP3R1 provide useful models for determining
whether XeB can effectively block the cleaved channel and restore Ca2+ homeostasis.
Defining the Role of InsP3R1 Proteolysis in Cell Death Pathways
The work presented in this dissertation supports the causal role of calpain-cleaved
InsP3R1 in neurodegeneration and lays the framework for future investigations studying
the cleaved channel in cell death pathways. An obvious question is, does blocking
calpain proteolysis of InsP3R1 prevent cell death? Unfortunately, this is experimentally
difficult to answer as calpain sequentially cleaves InsP3R1 into 200, 130 and 95 kDa
carboxyl-terminal fragments (Magnusson et al., 1993; Igwe and Filla, 1997). Preventing
calpain cleavage of the channel would require mutation of all 3 cleavage sites. However,
only the site responsible for generating the 95 kDa fragment has been identified (Chapter
2). Investigations of the ~95 kDa caspase-3 cleaved form of InsP3R1 could provide some
insights.

In one study, wt, caspase-cleaved, and caspase-resistant InsP3R1 were

expressed in InsP3R deficient B-lymphocytes to examine the impact of InsP3R1
proteolysis on apoptotic cell death (Assefa et al., 2004). Expression of caspase-cleaved
5

J. Molgo, via personal communication with G.E. Stutzmann, October 16, 2011
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InsP3R1 accelerated apoptosis in response to staurosporin and B-cell receptor stimulation
compared with wt-InsP3R1. In contrast, cleavage-resistant InsP3R1 dramatically slowed
apoptosis to levels observed in InsP3R deficient cells, and prevented Ca2+ overload and
secondary necrosis. We speculate that calpain-resistant InsP3R1 would afford similar
protection against cell death. Since generating a calpain-resistant InsP3R1 mutant is
complicated at this time, future studies should focus on investigating the potentially
protective effects of blocking Ca2+ release through the cleaved channel.
The proximal location of caspase and calpain cleavage sites within the primary
amino acid sequence of InsP3R1 further imply that proteolysis of InsP3R1 is critical to
cell death. This structural redundancy may be a fail-safe for cell death pathways, as there
appear to be functional similarities between the caspase- and calpain-cleaved forms of
InsP3R1. The results presented in this dissertation regarding the effect of calpain-cleaved
InsP3R1 on Ca2+ homeostasis and cell death are similar to previously published studies of
caspase-cleaved InsP3R1 (Assefa et al., 2004; Verbert et al., 2008), suggesting that
channel proteolysis by either caspase or calpain may produce a similar effect.
Interestingly, InsP3R1 digestion with caspase in vitro seems to prevent further proteolysis
by calpain (unpublished observation). The implications of this are unclear, however it
appears that InsP3R1 proteolysis by either enzyme alone is sufficient for cell death.
Importantly, both caspase (Haug et al., 2000) and calpain (Chapter 2) cleavage of
InsP3R1 are early steps in the molecular injury cascade suggesting a role for channel
proteolysis in both the initiation and execution of cell death.
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The idea that caspase- and calpain-proteolysis of InsP3R1 provide a convergent
pathway for cell death is further supported by evidence that there is considerable overlap
between caspase and calpain proteolytic systems (Wang, 2000), and that calpain
inhibition can shift cell death from calpain-mediated necrosis to caspase-mediated
apoptosis (McGinnis et al., 1999; Zhu and Uckun, 2000; Neumar et al., 2003).
Importantly, immunohistochemical staining for caspase- and calpain-specific substrate
cleavage in ischemic brain tissue demonstrates distinct spatiotemporal patterns of activity
for each enzyme (Zhang et al., 2002). Thus, InsP3R1 proteolysis, by both caspase and
calpain, may play a more diverse role in post-ischemic neurodegeneration than currently
appreciated.
In ischemic brain injury, the effects of calpain-cleaved InsP3R1 on impaired ER
Ca2+ buffering (Chapters 2 and 3) may be compounded by proteolysis of other substrates.
For example, calpain may further increase ER Ca2+ release by altering InsP3 processing.
Calpain cleavage of the B isoform of InsP3 kinase prevents its localization to the ER
membrane (Pattni et al., 2003), where it is responsible for converting InsP3 into InsP4
(Irvine et al., 1986), which cannot activate InsP3Rs. Therefore, calpain proteolysis of
InsP3 kinase could reasonably increase the half-life of InsP3 (Bevers and Neumar, 2008).
This in turn would likely increase InsP3 concentration, thereby activating more InsP3Rs.
Increased InsP3 half-life also has interesting implications for the activity of
heterotetrameric InsP3Rs with cleaved and full-length subunits following ischemiareperfusion. We postulate that calpain proteolysis of individual subunits results in a
gradual shift away from InsP3-dependent Ca2+ activation. In the absence of InsP3, this
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means channel Po increases with the number of subunits that are cleaved. In the presence
of InsP3, channels with non-cleaved subunits should have higher Po.

Although

understanding the precise, complex function of heterotetrameric channels requires
additional studies, based on this rationale, we predict that extended InsP3 half-life
resulting from calpain cleavage of InsP3 kinase would result in a net increase in ER Ca2+
release over time. Additionally, proteolytic modification of SERCA could impair ER
Ca2+ sequestration. While data demonstrating calpain-mediated cleavage of SERCA is
tenuous, the predicted effect of proteolysis is a decrease in Ca2+ uptake into the ER
(Parsons et al., 1999; Bevers and Neumar, 2008). Inhibition of ER Ca2+ store filling by
impaired SERCA function can itself lead to depletion of lumenal ER [Ca2+] over time,
and calpain-cleaved InsP3R1 would certainly accelerate the effect.

In our model

expressing capn-InsP3R1 in Neuro-2A cells, we observed slowed ER Ca2+ uptake,
enhanced ER Ca2+ leak, and decreased steady-state ER [Ca2+] compared with controls
(Chapter 2).

In primary neuron culture, we observed increased resting [Ca2+]i and

impaired ER buffering of Ca2+ influx in neurons transduced with capn-InsP3R1 (Chapter
3). These data indicate that, to a certain extent, the rate of Ca2+ leak through capnInsP3R1 is able to exceed the rate of Ca2+ uptake by functional SERCA.

Under

conditions in which calpain cleaves both InsP3R1 and SERCA, the impact on intracellular
Ca2+ homeostasis would likely be far more catastrophic. Together, these alterations in
ER Ca2+ release and sequestration could represent an irreversible point of cellular injury,
signaling post-ischemic neurodegeneration through cytoplasmic or mitochondrial Ca2+
overload. Better understanding of the sequence of these proteolytic and Ca2+ signaling
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events, and identification of the calpain isoform(s) responsible may point to new targets
for intervention in ischemic brain injury.
Implications for Therapeutic Intervention in Neurodegenerative Disease
The work presented in this thesis advances our understanding of the functional
consequences of InsP3R1 proteolysis and the broader role of the cleaved channel in
neurodegeneration.

Based on our results, we propose that blocking calpain-cleaved

InsP3R1 is a promising target for therapeutic intervention following ischemic brain
injury. Moreover, calpain proteolysis of InsP3R1 may be an important component of cell
death pathways in a number of other neurodegenerative diseases characterized by
disrupted Ca2+ signaling.
Translation of our investigation of calpain-cleaved InsP3R1 into an in vivo system
provides a potentially exciting and useful model for testing the neuroprotective efficacy
of new therapeutic agents. Using intracranial injection and viral vector mediated gene
delivery of capn-InsP3R1, we successfully expressed the truncated channel in neurons in
the adult brain, and observed degeneration of CA2 hippocampal neurons (Chapter 3).
The selective vulnerability of this brain region lends itself to histological and
stereological quantification of neuronal death.

This in turn provides a simple,

quantitative assay of neuroprotection afforded by potential therapeutic compounds.
Limited neurodegeneration in this model also allows for studying compound effects in
healthy, uninjured cells.

Furthermore, using an in vivo system necessarily involves

screening compounds for bioavailability in the brain, making results highly translatable.
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Depending on results from in vitro experiments proposed above, XeB might provide a
useful starting point for drug testing in our in vivo model.
Finally, our antibody directed against calpain-cleaved InsP3R1 (Chapter 2)
provides a valuable tool for examining InsP3R1 proteolysis in other neurodegenerative
diseases. Similar to data from ischemic brain injury, reductions in InsP3-binding have
been reported in brains from patients with Huntington’s (Tanaka et al., 1993) and
Alzheimer’s diseases (Young et al., 1988; Garlind et al., 1995; Haug et al., 1996).
Additionally, studies using animal models of excitotoxic injury (Haug et al., 1996) and
prion disease (Lee et al., 2010) report decreased InsP3R expression, although Western
blot analysis of InsP3R only examines the high molecular weight, full-length protein (260
kDa). Calpain proteolysis of InsP3R1 could explain these results. Our cleavage specific
antibody provides a sensitive way to detect calpain proteolysis of InsP3R1 in brain
homogenates and fixed tissue. Future investigators could utilize this antibody to screen
animal and patient tissue for cleaved InsP3R1. Regardless of which neurodegenerative
diseases calpain-cleaved InsP3R1 is identified in, these results will lay the groundwork
for diverse future investigations of the broad neuropathologic role of InsP3R1 proteolysis.
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